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PART I. INTRODUCTION. 
(i) Pli.El,I1uINARX CONSIllERATIONS. 
In his inaugural lecture as Regius Professor of Physic 
at Cambridge University in 1946, Sir Lionel Whitby said: "One 
has often heard it said that Medicine is an art and not a science. 
In my own experience, this platitude has usually been a cloak to 
cover ignorance of some modern scientific procedure. The simple 
facts are that medicine is both a science and an art. It is true 
that medicine will never be an exact science, because the normal 
variations in individuals have such a wide range that automatic and 
mechanical treatment is prohibited, whilst every patient requires 
a different method of approach according to his psychology. This, 
the frequently ridiculed bedside manner, which secures.the confi- 
dence of the patient, is of fundamental importance in practice; 
it is an art which is inborn and not acquired. Nevertheless, even 
the most confirmed artist cannot now neglect to keep up to date 
with the facts and findings of science upon which his diagnosis and 
treatment must be based ". 
With increasing knowledge of aetiology and pathology, empir- 
ical methods of treatment have been replaced by those based on lab- 
oratory experiment, but before such remedies are used on man, much 
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preliminary work is needed to ensure that they are not unduly 
toxic and that they do alleviate or cure. :oven though the more 
poisonous substances are eliminated, it cannot be assumed that 
because drugs are effective and non -toxic in animals, they will 
also be in man. 
Some drugs have different action on different animals. 
Morphia, for example, is a depressant in the dog but frequently 
a deliriant in the cat. Digitalis and others of its group have 
a variable degree of toxicity according to the species receiving 
them: Rodents, Toads and the Grass -snake are particularly resist- 
ant. The fatal dose for rats is one thousand times greater (per 
Kilo) than that for cats and thirty times as much as rabbits. 
Similarly pigeons tolerate intravenously 25 times as much (per unit 
of body weight) as do cats. In perfusion experiments different 
reactions occur in the hearts of frogs and toads. Within a species 
also there is marked variation in response to drugs. De Lind van 
Wijngaard (1926) who examined the variability of response of 573 
cats to a given preparation of Digitalis found that the individual 
lethal doses were distributed over a wide range. As a result he 
defined the Mean Lethal Dose since used as a basis for drug stand- 
ardisation where chemical estimation is not possible. 
Since individual variation is so marked, the use of exper- 
imental animals necessitates considerable forethought, both as re- 
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gards the species, for the reasons stated above, and the conditions 
in which they are used: the Hogben Test for pregnancy using enopus 
was not considered by some investigators (Shapiro and Zwarenstein 
1933) to be reliable because they did not understand the care these 
toads must be given in captivity, but once these difficulties had 
been overcome (Landgrebe 1939) the test proved simple and trustworthy. 
One way of decreasing the bias due to individual variations in non- 
lethal tests, e.g. insulin standardisation in rabbits, is for the 
control and experimental groups of animals of one days' work to be 
used next day respectively as experimental and control groups. 
Before the effect of a drug on an organism in an animal can be 
tested it is necessary to know something of the habits of the org- 
anism and to have available an animal which is susceptible. Until 
the discovery that the ferret is susceptible to influenza, all re- 
search on that infection was held up for lack of a suitable exper- 
imental animal. Having found such an animal, the course of the 
disease must be carefully studied to see that it corresponds with 
its human counterpart; or what lessons we can learn from differ- 
ences between the two. Researches on avian malaria have identi- 
fied part of the life -cycle of the plasmodium not as yet found in 
man though we have good reason to postulate its existence on other 
grounds. 
The need to validate the relevence of conclusions derived 
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from laboratory experiments by the proper study of mankind arises 
also from the fact that the results of in vitro experiments are 
not always confirmed by parallel experiments in vivo. In peni- 
cillin research, four fractions were originally-discovered which 
had different degrees of anti- bacterial efficacy in vitro, the 
fraction designated K being much more effective than the others, 
but the K fraction is in the human body so rapidly destroyed that 
its anti -bacterial action is negligible. In the conduct of ex- 
periments of this kind it is essential to eliminate all factors 
liable to bias results and to make due allowance for experimental 
inaccuracies which are bound to occur despite the greatest care. 
These factors and the range of variation from the individual mean 
can be minimised by maintaining a large number of cases or of ex- 
perimental animals under standardised conditions. 
Whether the subject is man or another species, Therapeutic 
Trials can be defined as "Objective scientific experiments in which 
are controlled all known variables likely to bias the subjects and 
objects involved. The purpose of such an experiment being to 
evaluate a single method, or to compare different methods of treat- 
ment". Investigations on man himself are not so simple as those 
on animals. The circumstances which call for control are more di- 
verse and the co- operation of the experimental subjects is more 
difficult to obtain especially if the social machinery of medical 
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care lacks co- ordination. The Army, however, is particularly 
well suited as a population for experimental purposes. It is 
about the size of a small nation, but unlike most nations is com- 
pletely documented with regard to its age and sex distribution and 
to the social background of its citizens. It possesses an all -in 
system of social medicine entrusted to a corps of medically trained 
men responsible to a central authority for the prevention as well 
as for the cure of disease: furthermore, it maintains a comprehen- 
sive system of medical documentation. What is well -nigh impossible 
in civilian life thus becomes a commonplace, i.e. controlled experi- 
mentation on a large scale by pooling the results of many research 
workers. 
It is the object of this thesis to examine Army experience 
of therapeutic trials. The major factual contribution to this 
thesis is the section dealing with syphilis therapy in. the Army. 
For the conduct of this the candidate was wholly responsible, with 
such clerical assistance as given by junior members of the Army 
Directorate of Medical (statistical) Research. The same is true 
of the sections dealing respectively with Malaria and with Internal 
Derangement of the Knee. The other sections record collaborative 
investigations in which the candidate participated as a member of a 
team of investigators. 
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(ii) CHOICE OF GROUPS FOR ial'eRIN`Fi ,'N1 AAD CÜiVTRÜL, 
In determining the degree of human efficacy of a drug 
already known to be effective in vitro and in animals, it is necess- 
ary to study at least two groups of individuals: one treated with 
the experimental drug, the other as the Control group. The latter 
are usually treated with another drug whose effects are known. Al- 
ternatively, they may receive no treatment other than some neutral 
substance superficially resembling the drug being tested, as a safe- 
guard against intrusion of the patient's suggestibility. Care in 
the choice of the two groups is of considerable importance for two 
principal reasons: (a) they must be of a similar composition with 
respect to all circumstances known to be relevant or putatively 
relevant to the prognosis; (b) they should be selected at random 
to minimise bias arising from unsuspected agencies contributory to 
the effectiveness of the treatment. Prejudicial selection is most 
easily avoided when the trial is carefully planned beforehand, 
being thus an Ad hoc Enquiry. Unfortunately it is not always poss- 
ible to plan a trial beforehand, and much valuable information may 
be obtained by a Post hoc Enquiry. 
.d hoc Enquiries: These may be planned for what may be 
termed (1) Confined Po ulations in hospitals, barracks or similar 
cox:iunities; (2) Dispersed Populations. 
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(1) Confined Populations. These are communities which 
are to a considerable extent controllable. They are patients in 
bed, soldiers in barracks, or children at school. Selection of 
individuals for experimental and control groups in such communities 
is most satisfactorily done by allocating individuals in turn to 
each of the different groups. The individuals may be already in 
bed, in which case they can be allocated alternately to the differ- 
ent treatments. In out -patients and casualty departments, or in 
Medical Inspection Rooms in barracks, the patients may be allocated 
alternately as they arrive. This method of choice is the surest 
way of obtaining random samples. 
When the end in view is the efficacy of preventive measures 
in the epidemiological field, such alternate selection of individuals 
cannot be used since it interferes with epidemic spread within the 
group. The whole group must be alike, and alternate groups must be 
the basis of comparison. In a trial of Influenza vaccine in Army 
centres receiving batches of new recruits for training at regular in- 
tervals, a whole intake was used as a group; if an epidemic were to 
develop, the incidence of influenza in a clear minority or a clear 
majority of the group indicated the efficacy or otherwise of the vacc- 
ine, but a middle result might indicate either an avirulent influenzal 
epidemic, a high level of active immunity among the individuals, or 
an ineffective vaccine. If the group consisted partly of vaccinated 
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and partly of non -vaccinated individuals, providing the vaccine 
were effective, the vaccinated persons would probably not be carr- 
iers and therefore the spread would be hindered. The investigat- 
ors would be left in doubt as to the result since there could be 
no majority or minority of individuals developing influenza. 
(2) Dispersed Populations. These are communities which 
are not easily controllable in that they are not living or working 
within the same institution. The method of selection just described, 
or a version of it, may also be possible here. Army individuals 
may be selected by their personal numbers which are allocated on en- 
listment. The terminal digit is usually taken in such cases, e.g. 
all men. with 5 as the last figure, thus avoiding any possible bias 
due to simultaneous enlistment of men of the same age groups, and 
hence one block of numbers tends to be allocated to one age group. 
Among civilians, the method of alternate selection may be applied 
in alphabetical order: by this means the Jones are equally divided, 
and the Scotsmen. with prefix "Mac ", but this point would need to be 
watched. Similarly, the inhabitants of a street can be taken by 
alternate houses. 
Post hoc ,;nquiries. In the past the commonest method 
of analysing results of therapy has been re-examination of individual 
patients or extraction of information from them by mail after an in- 
terval of time. This form of approaoh may be the only possible 
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method, but it introduces many sources of bias which have usually 
been ignored. During the course of years the circumstances att- 
endant on the use of a treatment inevitably alter, the skill and 
technique of the therapist may change, nursing may be better or 
worse and carried out in better or worse conditions, materials 
used may vary in quality and availability, and other conditions 
may vary pari passu. Death from other causes may remove treated 
individuals from the census. Others will not reply to communicat- 
ions from the enquirer, some of them dissatisfied with the treat- 
ment because it was unsuccessful, or others, themselves cured, un- 
able to see advantage to themselves in responding. 
All these possibilities bias the results of a follow -up 
enquiry and do not necessarily balance out. Often they are un- 
avoidable in a follow -up conducted by an individual clinician; and 
too often are aggravated by sources of erroneous interpretation due 
to faulty records or defective analysis. For instance, insufficient 
attention may be given to the age- distribution of the individuals con- 
stituting the experimental group, regardless of the fact that age 
affects both the likelihood of incurring the condition under invest- 
igation and the response to its treatment. Post hoc enquiries which 
are to accomplish useful results have to take cognizance of all these 
weaknesses. To this end a method similar to that carried out of 
recent years in the Array will be possible when civilian hospital 
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records are organised to make complete statistical information 
available. The most satisfactory form of follow -up is that in 
which all cases are personally seen and none are omitted except 
those which can be satisfactorily accounted for by death from a 
known cause or by medical reports from other sources. This 
method has obvious limitations since the patients often have re- 
moved to other districts and do not wish to go to the inconven- 
ience of travelling long distances. The Malaria. Paludrine trial 
cited below was followed by post with 1(4, response, although 
several requests were needed in some cases to elicit a reply. 
In the Array, a system of documentation has been built up 
which permits easy extraction of information. All medical docu- 
ments relating to in- patient treatment are filed in a Central 
Medical File after various details have been abstracted, coded, and 
transferred to punched cards. The latter are filed separately by 
diagnosis according to the theatre in which the patient was serving 
at the time of his admission to hospital 
sorting, the coded details can be listed 
the information required. For example, 
By use of mechanical 
or tabulated according to 
the machines, as well as 
giving the number of cases of different diseases occurring in a 
given theatre of war during a. stated period, can also provide data 
with respect to Army number, age, sex, arm of service, date of ad- 
mission to and discharge from hospital, and disposal on discharge 
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therefrom of every patient treated for a specified disease or 
injury. By linking the Army numbers, access can also be ob- 
tained to the subsequent Army history of each case through a 
central card index maintained for every soldier in the British 
Army. These lists of Army numbers can also be related to the 
Central Medical File so that the original documents themselves 
can be consulted. Post hoc enquiries in the Army have thus 
been carried out with considerable success. Various means have 
been used to provide control groups, but usually the difficulty 
has been overcome by contrasting the experimental therapy with 
one of known efficacy. 
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(iii) HOSu1OGl;IVBITY OF ï;tl'1tiRIlv%;IVTAL COIdTROL GROUPS. 
Before beginning the analysis of an investigation of the 
sort under discussion, it is essential to ensure that the groups 
chosen are homogeneous. Factors biasing results have already 
been frequently referred to and they must now be dealt with in de- 
tail. They may be classified as Personal, Constitutional, Envir- 
onmental, and Documentary. 
(a) Personal Factors; In this context these include Age, 
Sex, and Marital status. Certain diseases are known to have a 
differential incidence with regard to each of these, and some means 
must therefore be available to enable any resulting bias to be elim- 
inated or counter -balanced. The age composition of the Army changed 
considerably between 1939 and 1945, there being a steady fall in the 
proportion of very young men. and a concomitant decrease in the oldest 
(over 45) age group. Direct comparison of any two near years was 
therefore misleading, since the major sources of wastage varied acc- 
ording to which age group predominated, and the emphasis shifted from 
Tuberculosis to Peptic Ulcers, and from Peptic Ulcers to Bronchitis 
as the predominance of older men increased. The Á.T.S. was at all 
times a younger population than the male Army personnel, therefore 
comparison between crude morbidity rates for men and women may give 
rise to even more erroneous conclusions than comparisons of morbidity 
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rates for the same class of personnel at different stages of the war. 
To eliminate the distorting effect of age, all Army figures were age - 
standardised by a method similar to that used by Registrars- General 
in their tables of crude and standardised death rates. For instance, 
among the Army in Britain in 1943 the female -male ratios of the inci- 
dence of Peptic Ulcer was 1:10, but after age- standardisation the 
ratio was strikingly reduced to 1:5. Marital status is also import- 
ant, particularly with respect to women. A married woman most fre- 
quently does not undertake industrial employment and to that extent 
leads a sheltered life, consequently a group mad up of a mixture 
of married and single women may be biased by a greater or lesser 
number of industrial workers. Occupation as a factor in therapeutic 
trials is considered later as an environmental factor. 
(b) Constitutional Factors: It is also desirable to pay 
due regard to Ethnic Origin, Family History, Diathesis and previous 
Medical History. The ethnic origin of the individuals in the 
groups is not a major difficulty in the British Isles, but in other 
countries, especially in the United States of America, different 
samples of the population may vary considerably with respect to their 
ethnic composition. This factor is important, not only because of 
natural immunity to a disease, but also because of immunity acquired 
by continual contact with endemics and epidemics. An Army enquiry 
into the health of troops stationed in the Middle East during 1944 
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did in fact show that the incidence of morbidity and mortality 
varied widely between troops respectively of European, Asiatic 
and African stock. For example, the following figures compare 
morbidity and fatality rates with respect to Tuberculosis (all 
sites), and Pneumonia among (a) British troops enlisted in Britain, 
(b) Indian troops, and (c) African native troops enlisted mainly 
in Bast Africa: 
iviorbidity Incidence Ratios: 
Indians :British 






4.5 : 1 0.9 : 1 
8.4 : 1 6.1 : 1 
Deaths as % of Cases Deaths as % of cases 







Fatality Ratios (calculated from above): 
Tuberculosis Pneumonia 
Indians : British 7.0 . 1 0.9 : 1 
Africans : British ... 3.9 : 1 0.6 : 1 
In many experiments, the previous medical history of the 
individuals may not be important but its neglect may sometimes give 
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rise to misleading results. In investigating the epidemiology 
of Infective Hepatitis cases of jaundice due to toxic factors such 
as Virus infection following intravenous arsenic therapy or plasma 
transfusion will be disclosed only if histories are carefully taken 
with these points in view. Similarly, family history and Diathesis 
are issues which need to be considered, e.g. in a survey of Nephritis, 
a gouty diathesis might be important. In the study of a hereditary 
condition particular attention must be paid to locality. Recessive 
characteristics such as Retinitis pigmentosa appear more frequently 
as a result of inbreeding, and hence may display a differential in- 
cidence in more or less isolated communities. If one group in the 
experiment were to contain an undue preponderance of individuals 
from, say, the North-Last of Scotland, the results of that group 
might be unfavourably biased. 
(c) Environmental Factors; These include Habitat, In- 
come and Occupation. If we use Habitat to describe all the condit- 
ions which are responsible for differences between the mode of life 
of one man and of another, it includes the influence of income and 
occupation. In this context, we refer more especially to climate, 
urban and rural dwelling, density of population, local fauna and 
ease of spread of epidemics. The types of disease prevalent in a 
locality are to a large extent governed by the climate in so far as 
certain infective agents are capable of existing only in hot humid 
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places, while others are rampant only in cold places. Weather 
conditions affect not only the ability of an organism to survive 
but also the capacity of the individual to resist infection. 
Hence, as is well known, the incidence of certain diseases varies 
with the seasons, for example the rxanthemata all occur at about 
the same time every year. With decreased rainfall, decreased 
dilution of contaminants in water increases personal liability to 
Snteric Fever. In India increased rainfall brings the vibrio of 
Cholera into the wells of the lowlands and epidemics immediately 
occur. Temperature also determines the local fauna, and hence 
the existence of particular vectors of disease. Typhus occurs 
most commonly in the winter months when people wash less and con- 
gregate for warmth, enabling lice to multiply and pass from one 
person to the next. 
Many of these locality effects may be minimised if the 
individuals have a sufficiently large income: and it is a common- 
place that some diseases, particularly Tuberculosis occur most fre- 
quently among the lower income groups owing to bad housing condit- 
ions, overcrowding, and inability to feed and clothe properly. 
Occupation also has its attendant hazards by no means circumscribed 
by such threadbare themes as factory accidents, silicosis, or T.N.T. 
toxicosis. For instance the worker may be involved in travelling 
long distances from his home, or compelled by the nature of his work 
to irregular habits of feeding. 
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(d) Documentary Factors: In the Army, the difficulties 
stated above can usually be overcome: but another remains. In 
Britain service patients were treated throughout the war either in 
Military Hospitals or in B.M.S. Hospitals under the control of the 
Ministry of Health. Treatment and documentation in the two types 
of hospital was similar but not always identical. :Patients were 
sent to either type of hospital in accordance with policy based on 
the number of beds, specialists etc. available, and the policy pur- 
sued by the Army altered with changing circumstances. In therapeut- 
ic trials quoted later, viz., those relating to Impetigo and Internal 
Derangement of the Knee, attention is drawn. to a striking difference 
with respect to duration of stay in hospital of patients respectively 
treated in Military and in L.ELa. hospitals. Thus sample populat- 
ions are strictly comparable only if drawn from comparable institutions. 
It is evident that uniform documentation must be established . 
to carry out a therapeutic trial involving different therapeutic 
centres. An enquiry into the Efficacy of Penicillin in War b'+ounds 
recently carried out at the War Office for the Medical Research Coun- 
cil was in fact jeopardised by oversight in this connexion. The 
experimental group consisted of casualties in North -4est Europe, while 
the control group consisted of casualties in Italy. Owing to diff- 
erences of policy with respect to documentation of different medical 
units the experimental group was weighted by a far greater proportion 
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of very seriously wounded cases, and in consequence included 
many more deaths. Uniform documentation involves not only use 
of the same types of document and their complete availability, but 
also uniformity in completing the document so that the answers 
allow of no ambiguity either in matter of fact or degree. 
In attaining homogeneity of samples in the many ways 
referred to above, it must also be stressed that no catalogue of 
avoidable errors is exhaustive. While all known factors likely 
to bias the selection may have been eliminated or allowed for in 
planning the experiment, there may always be others which could 
not be foreseen. The only safeguard against such is the use of 
artifices of randomisation, as for instance, alternate selection 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Date of oommemement of treatment 
I 
TREATMENT 
GONORRHOEA - U.K. 
Age 

















days from onset to c®mencement of treatment. 
days duration of treatment. 
COMPLICATIONS 
Conjunctivitis Iritis Arthritis Epididyno- orchitis. 
Prostatitis. Vesioulitis Others Nora 
Interval from once` days 
JAUNDICE Present Absent 
Interval start of treatment to onset of Jaundice days 
RELAPSES 
Interval Aye from completion of treatment torelapse 




No.of previous attacks (or relapses) days Nct specified 
Interval Pram completion of last attack days Not specified 
Treatment:- Sulphathiazole HgOCN T.A.B. 
Sulphanilamide P.Y. C.C. 
Sulphadiazine Others 
Sulphapyridine 
Penicillin Not specified 
F1g.2 
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(iv) )LSIGDI OF Dí1CUMENTS. 
In both ad hoc and post hoc Enquiries some means must be 
found to attain uniformity with respect to provision and abstract- 
ion of information. The simplest method is to design a document 
specifically for the purpose. Such a proforma should record only 
details relevant to an investigation, set out in such a way that 
the eye is able to perceive at a glance what it is looking for. 
It can be designed either for ultimate sorting by hand or for ab- 
straction on to the punched card for mechanical tabulation. If 
designed for hand sorting, the data on the proforma may best be 
listed either for the relevant word to be underlined or with a 
box or space alongside for the insertion of a mark such as a cross 
or a figure; each item being mutually exclusive to avoid ambiguity 
and to facilitate numerical checks. Every section must therefore 
include an item for information not specified, and an item for 
"other ", to cover all possibilities: by this means no case in un- 
accounted for in any section. If mechanical tabulation is envis- 
aged the lay -out is similar but each item must bear a number, and 
the recorder will mark the relevant number in a box printed on the 
right -hand edge of the page. This method allows a punch -clerk to 
transfer the code number directly to a punch -card and avoids the 
intermediate step of employing a clerk, unskilled in scientific 
IMEDICAL CADE SLIP (41osp1.1-c..t G4.) 
I THE mtE IN WNitN TREATED m, timi 
2 
e 
PERSONAL Ofl ARMY Nuri Eft 
3 DISCRIMINR -fioN OF PERSONNEL 
ARM OF SEPaICE 1%111 




\ TYP. 6F HOSP1TL OJ 4sß 
7 'ES of 11EICAL UNIT 
\\ 
9 
11oNT AND YEAR OF 1sß RDSflSSIOt' 
A,- \4 -3118, i Gvnitgóle} ,iom 
= i1RATiON OF STAY IN FORN4ARD MEDICAL OMIT 
OR RECEPTION STATION (fort. A.F. W.3118) 
10 DURATIoI1 OF STAY IN HOSPITAL 
II DURRTSON OF STAY IN COI VRLEScE.NT DEPOT \,` 
12 DURATION OF STAY- TOTAL (4 +i0 +!') 
13 RESULT OH DISCHHRGE - \ 
\-:\ I 4 DISEASE OR It(1UPY 
15 E.A. OR NoT \ \ \\ 
16 WEAPON OR AGENCY OF IHIURY \ \ \ \\
17 NEW DISEASE SUPERVENING OR 2nd bISEASE 
IS TREATMENT "`\ 
19 MARITAL STATUS IX\` 
\.ZO TYPE OF ENGAGEMENT\ 
21 PERIOD OF SERVICE IM THEATRE (In moni65 
22 TYPE OF ARMY DOMICILE 
23 SITE OF INIIIRY 
2y- TISSUES INYoL '4Eb 
CODED BY CHECKED BY 
Fig .3 
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terminology, to interpret the information in the process of coding 
it, a step which increases the chance of mistakes. 
Mechanical tabulation is not worthwhile if the number of 
cases is small, it finds its greatest value in organizations where 
records are always maintained with this end in view. Hand sorting 
may be very laborious and may take a long time, but is more flexible 
than mechanical tabulation, and may disclose information which would 
otherwise escape notice. For hand sorting it is important that 
the paper or card on which the proforma is printed should be semi - 
stiff, neither thick nor very thin. Specimen proformas which have 
been used in various enquiries designed for hand sorting are illus- 
trated in Figures 1 and 2. Figure 3 shows an Army form for mechan- 
ical tabulation, but necessitates the employment of clerks skilled 
in coding scientific terms. 
21. 
(v) CHITJa:;KIA OF aFICACY. 
Ideally, estimation of the effect of a therapy should 
rely upon exactly measurable criteria of which there are very few 
in the human field. It should eschew personal impressions which 
may have no objective validity and are difficult or impossible to 
check. We have thus to ask: What objective criteria are avail- 
able? 
The course of any disease terminates with cure or with 
death. Which of these will happen depends upon the disease it- 
self, the effectiveness of the treatment and time factor. In the 
absence of treatment, diseases may be classified as follows: - 
1. always fatal. 
2. always cured without complications. 
3. usually cured but otherwise fatal: sometimes 
accompanied by complications. 
4. becoming chronic. 
5. subject to. relapses. 
Under treatment the outcome may be any of the following: - 
1. The course of the disease may be unaffected. 
2. The patients may survive in contrariety to 
previous experience. 
3. Cure may be absolute, without complication or 
relapse. 
4. Complications may be prevented either in 
frequency or in severity. 
22. 
5. Complications may occur in a previously fatal 
disease, without death following. 
6. The risk of relapses may be reduced. 
7. There may be variation in the time factor in 
relation to each of the foregoing, e.g. death 
may occur at a later stage of the disease. 
8. The treatment may maintain the status quo, e.g. 
Insulin in Diabetes. 
A more detailed examination of the above suffices to indi- 
cate possible yardsticks of therapeutic efficacy. 
(a) Mortality Rate. We may consider the risk of death with 
respect to a disease as (1) immediate, (2) delayed, Accordingly 
we may use as our criteria of efficacy one of two indices, as cir- 
cumstances indicate. 
(1) The Immediate Mortality Rate may be defined as that 
occurring within a period after treatment during which a level of 
response is capable of being attained, i.e. the period up to discharge 
from hospital. A patient is not moved from hospital until he has 
recovered sufficiently to permit him being moved and only very rarely 
if he is expected to die within a short period. The implication in 
utilisation of this period is that the patient has recovered to a 
measurable degree. It would be exceptional for a patient to be dis- 
charged home without attaining this degree of recovery. The actual 
duration of the.period cannot be taken as a measure since it depends 
so very much more upon the individual patient and his powers of re- 
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cuperation than upon the efficiency of the therapy. In any com- 
parison using this yardstick, care must be taken to ensure that 
administrative policy in relation to such classes of patients was 
the saine at each hospital and throughout the period. 
(2) Life Expectation: The expectation of more or 
less prolonged life is in any circumstances dependant on the age 
of the individual, hence the only satisfactory measure of delayed 
risk of death is a comparison of the expectation of life of treated 
individuals at a given age with that of untreated individuals of 
the same age, in accordance with the actuarial method of the Life 
Table. The same method is adaptable to assessment of the risk of 
relapse as illustrated by the section below dealing with Syphilis 
Therapy. 
(b) Relapses. that is a relapse and what is not a relapse 
can usually be distinguished, but in suoh conditions as Gonorrhoea, 
Syphilis, Malaria and Infective Hepatitis the distinction between a 
relapse and a re- infection is not always easy to make. Signs and 
symptoms of re-infection and relapse are not easily separable: and 
their separation may involve an act of personal judgment, the value 
of which will depend on the experience of the investigator. 
Criteria of Relapse used in any trial must therefore be stated with 
precision to permit comparison with subsequent trials. This quest- 
ion is dealt with in the trials of Gonorrhoea and Syphilis therapy 
reported later. 
24. 
(o) Duration of Treatment: In diseases which do not 
usually have a fatal termination, treatment may be able to reduce 
the length of time during which the sufferer is incapacitated. 
Duration of treatment is therefore a possible yardstick of its 
value. Gonorrhoea and Impetigo trials discussed below illustrate 
its use and its limitations. Its limitations vis 2á-vis hospital 
administration, already mentioned in relation to documentation, 
are the subject of further comment in the Section on Internal De- 
rangement of the Knee. This criterion can be reliable only when 
patients are received in rotation in the same clinic and treated 
by the same doctors, nurses and administration; and should not be 
used when prolongation of treatment is due to the occurrence of com- 
plications, which themselves provide a criterion of efficacy. 
(d) Supervening diseases and Complications: This yard- 
stick can conveniently be used in situations such as those which 
prescribe recourse to mean duration of hospitalisation. The two 
may in fact be estimates of the same thing in different ways, al- 
though it is obviously inaccurate to judge different therapies by 
the speed with which they overcome the primary condition when this 
duration may be grossly prolonged by the occurrence of a secondary 
condition or complication. In estimating the efficacy of Penicillin 
prophylaxis in Battle Casualties, the incidence of infective compli- 
cations proved to be the only satisfactory criterion. Another ex- 
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ample of its applicability is comparison between frequencies of 
chest complications associated with use of different anaesthetics 
for a single type of operation performed on similar subjects. 
(e) Vocational Efficiency: Discharge from the Army in 
Category E (medically unfit for further service) constitutes a 
clear -cut measure of the severity of certain diseases after attempted 
cure, and has its industrial parallel in disablement. Any data 
which take account of personal efficiency, such as output per man - 
hour, rates of absenteeism, rates of promotion or increased pay can 
also be used to assess the effectiveness of previous treatment for 
a more or less disabling disease. Some criteria available in the 
Army are not available in civil life. Since every man and woman 
has a medical examination on enlistment and is assessed by medical 
category, change in the category necessitated by disease or injury 
provides information relevant to our present purpose: but there 
are many difficulties in the way of this method. Comparison of 
series of cases collected over different periods may contain popul- 
ations different with respect to their medical category composition. 
Army policy with reference to medical categorisation changed from 
time to time according to the man -power situation. At the time of 
greatest shortage low category men were upgraded to Al or sent to 
work in places where it had never previously been considered right 
for them to work. there policy changes have not occurred, then, 
change of medical category is a useful yardstick. 
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In the section on Internal Derangement of the Knee 
(I.D.K.) the subject of downgrading and discharge from the service 
is illustrated, and attention is drawn to the misleading results ob- 
tained if administrative factors are overlooked. In this context, 
in view of the frequency of football as a causative trauma a yard- 
stick of efficacy could have been the rate of return to full work 
of professional footballers after different methods of therapy. 
In choosing a satisfactory criterion, the opportunity of 
using additional secondary criteria should not be missed. Such 
secondary, or even equivocal criteria not only provide extra evid- 
ence, but also act as internal checks one upon the other. For 
the Therapeutic Trial of Gonorrhoea reported below three yardsticks 
were arailable. Where different therapies are used as standards 
for each other, it is advisable to have one established method as 
a basis for comparison. 
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(f) CURE. 
Since the body is continually in a state of repairing 
damage, our criterion of disease is not clear -out. All damaging 
processes call further defensive and repair efforts by the tissues 
and it is the degree of response required which governs the desig- 
nation of a particular attack as a disease. A disease may there- 
fore be defined as an injurious process by foreign organisms which 
necessitates more than a purely local defensive and repair effort by 
the body. Cure of a disease may be defined as the point at which a 
disease process is terminated, whether the body is or is not severely 
disabled by it. In this sense of the term Cure has no relation to 
the degree of resultant disability. ,After Broncho -pneumonia, the 
amount of fibrosis occurring in the repair process will determine the 
degree of disability, which persists. 
Whether such a definition of cure is or is not en rapport' 
with universal usage, it provides a pigeon -hole for the criterion we 
commonly employ, when we seek to evaluate a method of treatment 
applicable to lingering diseases (e.g. Eczema) which are not them- 
selves disabling, nor fatal nor prone to relapse after disappearance 
of the signs and/or symptoms. The arrest of the disease process as 
a criterion of remedial efficacy itself presupposes that we have the 
means of recognising it as such. Only if the differential diagnosis 
of a disease is clear -cut can we use cure as defined above to assess 
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the measures we employ in the patient's interest. 
In the practice of medicine certain conditions with clear - 
cut symptoms and signs which run a definite course occur with suff- 
icient severity and sufficiently frequently among the population to 
justify their denomination as specific entities. Where symptoms, 
signs and the course of a disease are less specific the synchronism 
or sequence may itself be sufficiently specific to rank as a char- 
acteristic syndrome: but it is by no means true that all conditions 
which have earned a name are singular entities either from a symptomat- 
ological or an aetiological viewpoint. When doubt exists about a 
correct diagnosis the physician may turn to a therapy designed for a 
specific disease as a diagnostic measure. In other words conversely 
to testing the efficacy of a therapy in a known disease. The de- 
limitation of the disease and the definition of cure became entangled 
for another reason. A particular microorganism may be classifiable 
in strains distinguished by no recognisable criteria other than their 
resistance to a particular drug, and the symptomatology of the dis- 
ease associated with one or the other may in fact admit no different- 
ial diagnosis, as is true of sulpha -fast and sulpha- sensitive cases 
of Gonorrhoea. From a clinical viewpoint we are here dealing with 
one disease which responds erratically to a specific treatment. 
From an aetiological viewpoint we might with propriety speak of two 
similar diseases for one of which the same treatment is completely 
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efficacious. 
In comparing results of therapy by recourse to the crit- 
erion of cure as here defined, it is necessary to pay regard to the 
possibility that the disease process could arrest without interfer- 
ence. It may therefore be necessary to define (1) the point at 
which cure is assumed to occur, (2) the indications for determining 
this point, and (3) the reason for accepting the indications and 
the timing as being the time of cure. However, more often than 
not, the yardstick of cure is used only when it is necessary to state 
the condition was cured within a given period: the exact moment at 
which it occurred does not matter. 
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(vi) SUMMARY OF PART I. 
Throughout this thesis, there has been constant reference 
to elimination of bias and the avoidance of 'selection'. The in- 
tention of a therapeutic trial is to obtain reliable information 
as to the efficacy of a drug. In designing the trial every consi- 
deration must be given to avoiding anything which will prevent an 
exact comparison between different methods of therapy. It is ess- 
ential to take stock of all factors which can be considered to be 
of possible importance and to control them. .absolute homogeneity 
is impossible of realization, but suitable devices for randomisation 
of test subjects should suffice to minimise bias due to unknown or 
unsuspected agencies in a large -scale investigation. What constit- 
utes a large -scale investigation must be considered with due regard 
to the magnitude of the difference an experiment is designed to de- 
tect. If we are comparing two methods of treatment either of which 
can guarantee at least 90% efficacy, the standard error of a sample 
of 900 is as great as 1%. We could not judge samples of 1000 each 
as certainly different unless they differed by more than 3 %. 
therapeutic trial must be regarded as a test of a procedure only in 
the conditions and circumstances of the trial. In the trial of 
Paludrine as curative treatment for B.T. Malaria, given below, the 
high relapse rates recorded, in the neighbourhood of 50jó, might tempt 
one to conclude that Paludrine is totally ineffective as an anti- 
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malarial drug. Other workers, using low dosage, but for a 
longer period of time, have in fact shown Paludrine to be an 
effective cure of B.T. Malaria. 
Post hoc statistical techniques to test for homogeneity 
of experimental data are sufficiently dealt with in theoretical 
treatises accessible to the research worker, but it is permissible 
to doubt whether such devices can suffice to safeguard against 
errors which first -hand experience of the subject -matter might 
anticipate. In this context we may recall Bacon's aphorism that 
radical errors in the first concoction cannot be cured by subsequent 
remedies however excellent. It is the aim of this Thesis to illus- 
trate how safeguards against erroneous interpretation emerge from 
the practical conduct of Therapeutic Trials and to show by an examin- 
ation of the credentials of particular therapies how any investigation 
of this sort is beset by pitfalls peculiar to itself. 
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PART II: ARMY EXPERIENCE OF SYPHILIS TREATMENT. 
1. INTRODUCTION. 
Experience of Syphilis therapy in the Army during the 
late war provides unique materials for assessing therapies in 
current use, and it is the aim of Part II of this thesis to assess 
their value. During the first phase of the war Army medicine re- 
lied exclusively on long -term arsenotherapy, later on short-term 
Mapharside with Bismuth. In the last phase Penicillin treatment 
replaced or supplemented the use of Arsenicals for a trial period 
pending the outoome of experience. In all, we are in a position 
to examine the results of eight procedures which we specify more 
fully below ( 5) : 
1. 2.4 mega units of Penicillin. 
2. 4.0 mega units of Penicillin. 
3. 2.4 mega units of Penicillin + 0.6 gm. Mapharside. 
4. 2.4 mega units of Penicillin + 0.4 gm. Mapharside 
+ 1.0 gm. Bismuth. 
5. Long -term Arsenio Therapy high aggregate dosage. 
6. Do. Do. law aggregate dosage. 
7. Long -term Arsenic Therapy + 2.4 Penicillin. 
8. Short -term Arsenic Therapy. 
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2. SOURCES OF NKTLRIAL. 
Long -term Arsenic Cases were traced through the War Office 
Central Card Index which supplied a nominal roll of all Syphilis 
oases admitted to hospital for treatment during the twelve months 
1943 -44. The same nominal roll also served for a survey of post - 
arsphenamine jaundice (Truelove and Hogben, 1947). Nominal rolls 
obtained from the Adviser in Venereology made it possible to trace 
cases undergoing initial treatment (by methods later specified) at 
Army Special Treatment Centres in Britain during the period Sept- 
ember 1944 to June 1946. During this period each Special Treat- 
ment Centre (S.T.C.) was treating all cases of early Syphilis with 
a standard schedule of therapy notwithstanding the duration or 
severity of the disease. Hence such nominal rolls should provide 
an unbiased sample of the total Army early Syphilitic population at 
home. By recourse to the serial numbers supplied by them, it was 
possible to extract hospital record cards (A.Fs. 1.1220) from the 
Central File of Medical Documents at the War Office and from the 
Central Syphilis Register (C.S.R.). The former furnished detailed 
information with reference to initial syphilitic infection and 
treatment. The latter supplied surveillance notes relating to 
each case. 
Many cases on the nominal rolls from S,T.Cs. were unservice- 
able for the following reasons:- 
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(1) patients from other Services, initially treated 
in military units were subsequently transferred 
from Army supervision; 
(2) some patients had had previous treatment for the 
disease; 
(3) some cases were congenital, tertiary, neuro- 
syphilitics or latent syphilitics; 
(4) the relevant documents of a small group were 
incomplete; 
(5) a large group of cases (here termed Defaulters) were 
demobilised too soon after treatment to permit 
surveillance. This circumstance is responsible 
for the disappointing yield of cases treated by 
the more recent Penicillin Therapy Schedules, but 
there is no reason to suppose that their exclusion 
gives rise to bias. 
All cases under consideration are Early. They had neither 
suffered previously from the disease nor undergone previous treat- 
ment, but otherwise include any diagnosed as Sero -negative Primary 
Syphilis, Sero -positive Primary Syphilis and Early Secondary Syphilis. 
The diagnostic criterion of Primary oases was presence of a primary 
chancre confirmed by detection of Treponema pallidum by dark ground 
examination, with or without positive serological test C assermann 
or Kahn). That of Secondary Syphilis was a positive Wassermann or 
Kahn Test together with such clinical manifestations as a rash, 
mucous patches or oondylomata (confirmed as such by dark ground ex- 
amination). 
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3. CRIT.r;RIA OF LFFICtiC IOUS T RLtiT L E NT . 
Inter alia we may judge the therapeutic efficacy of a drug 
in terms of the risk of relapse, or the frequency of beneficial 
response whether temporary or otherwise. Accordingly, we here 
distinguish two categories of cases as relapses and failures, the 
former among whom the benefit of treatment is only temporary, the 
latter because they fail to derive any manifest benefit at all. 
Any index which combines figures referable to both criteria is nec- 
essarily arbitrary, because we have no reason to suppose that a 
treatment which is accredited by a lower relapse rate will be 
accredited by a lower failure rate: and if the two methods of ass- 
essment point to different conclusions, no formula applicable to 
all diseases prescribes which should have priority. Since we 
cannot compute relapse rates without excluding cases which at no 
time responded to treatment, we have thus to apply to our data two 
independent criteria of efficacy: (a) what proportion of all cases 
treated fail to respond at any time; (b) among cases which do res- 
pond at some time, what proportion subsequently relapse. 
Considerations which did in fact guide our classification 
of cases as failures, relapses or cures, call for more explicit 
clarification. Both for diagnosis and for surveillance, Treatment 
Centres concerned in the present investigation employed the Q.uali- 
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tative Wassermann reaction (W.R.), the Qualitative Kahn Test (K); 
and Quantitative ditto (K.Q.). Owing to exigencies of the Service, 
the W.R. and Kahn were not always used together in surveillance; 
but Quantitative Kahn tests (K.Q.) performed in the majority of 
cases give evidence of serological trends. We here consider a 
serum to be positive when the laboratory reported any one of the 
following: W.R. +, K+ or K.Q. of 4 or more units. We classify 
as doubtful a result such as Kt, W.R. * or K.Q. readings of less 
than 4 units. Blood samples from each case were commonly examined 
both at beginning and end of treatment. The routine of surveill- 
ance entailed clinical and serological examination at 2, 4, 6, 9, 
12, 15, 18 and 24 months after completion of treatment. Lumbar 
puncture was performed at 6, 18 and 24 months. 
We here regard a case as cured, if it conforms to each of 
two criteria: (a) all lesions have healed at the conclusion of 
treatment; (b) the serological test is negative at the end of sur- 
veillance. We also regard as a cure, any case ending surveillance 
prematurely with one sero- negative test (e.g. W.R.) and one doubtful 
(eg. Kahn) if it satisfies each of the following criteria: 
(a) there has been consistent decline from an originally high titre; 
(b) there are no remaining clinical signs of syphilis. Clinical 
records (A.Fs. 1.1220) provide the information on which we rely for 
specification of relapse in accordance with either of the two criteria 
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on which we base the initial diagnosis, viz: (o) presence of 
fresh clinical manifestations in which Treponema pallidurn could 
be demonstrated; (b) positive serological test, if previous tests 
had been negative or of lower titre. Reappearance of Muco- 
cutaneous lesions in which T.p. is demonstrable provides clear - 
cut evidence of relapse; but the serological criterion is not, 
of itself, unequivocal. 
Many cases lost in the follow -up (Defaulters) were not 
sere -negative at the time. They were either sero- positive or 
serologically doubtful; and their previous serology may have 
been: (i) positive with a steady or rising titre; (ii) positive 
with a declining titre; (iii) consistently or at some time nega- 
tive. Cases we classify as failures, in contradistinction to re- 
lapses, are cases which did not become sero- negative within four 
months of the end of treatment but continued with a high titre or 
an increasing titre until they were lost to surveillance. In 
this context failure therefore means inefficacy of a treatment to 
reverse or to reduce the serological titre by the fourth month. 
There were few among the long -term arsenic series, and only among 
such as received small aggregate doses of arsenic owing to super- 
vening dermatitis or jaundice. In the Penicillin and short -term 
Arsenic series some failures renewed treatment as soon as there 
was clear evidence of defective response. The rest would almost 
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certainly have been re- treated, had they not defaulted. 
Cases defaulting from surveillance with a titre still posi- 
tive but steadily declining from an initially high level are ob- 
viously doubtful. Cases with a positive serum after one or more 
clear -cut negative tests during surveillance are by definition 
Relapsos at the month in which the become Lositive. Others classi- 
fied as doubtful had a doubtful serum reaction at their last sur- 
veillance before they defaulted, because further surveillance might 
have demonstrated a steadily rising titre or fresh muco- cutaneous 
lesions indicative of relapse. In a very few instances, a weakly 
positive serum reaction interrupted an otherwise consistently nega- 
tive surveillance. The subsequent negative clinical and serological 
trend, confirmed by absence of abnormality in the C.S.F., suggested 
that such isolated positive reactions were either of the falsely 
positive type or were due to laboratory errors. Little can be pre- 
dicted of a case which defaults from surveillance at the 2nd or 3rd 
month with a serum still positive or doubtful and without any stig- 
mata of clinical relapse. Since the time under surveillance is 
quite inadequate to disclose the ultimate trend, we have rejected 
them from our pool of data. Table I shows the percentage of all 
oases available for f ollaw -up in each series and those rejected for 
reasons here stated. 
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TABLE I. 
Percentage of cases ending with an equivocal 
serology rejected from the series on account 
of follow -up of less than four months. 
PRIMARY 









PEN: 2.4 163 0.0 119 0.8 
PEN: 4.0 44 6.8 30 6.7 
PEN: & MAPH: 113 2.7 59 10.2 
PEN: & MAPH: 
+ BISMUTH 92 3.3 56 14.3 
LTA: & PEN; 38 0.0 26 0.0 
LTA: (A) 84 0.0 67 0.0 
LTA: (B) 84 0.0 47 2.1 
STA: 38 0.0 42 0.0 
In Therapeutic Trials involving a communicable disease 
a common difficulty arises in connexion with delimitation of re- 
lapses and re- infections. Eighty -f ive cases in all treatment 
groups of our series were known to develop additional syphilitic 
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lesions. The venereologist's opinion as stated in the clinical 




It has hitherto been customary (hoore 1943) to exclude a 
diagnosis of reinfection unless consonant with all of the three 
following criteria: 
(i) "There must be proof that the patient had syphilis 
prior to the occurrence of the suspected second in- 
fection, and this proof must rest on the demonstrat- 
ion of spirochetes in a lesion or the occurrence of 
a positive blood Wassermann reaction in the blood 
serum, and not on clinical judgment alone ". 
(ii) "After an interval following antisyphilitic treatment 
and at a site other than that of the primary lesion 
of the first infection, there must develop a lesion 
with the characteristics of a chancre in which spiro- 
chetes can be demonstrated ". 
(iii) "That at the time of the supposed second infection 
the serologic test is negative; and that while under 
observation and during a period in which treatment is 
purposely withheld, the serologic test becomes posi- 
tive or the patient develops outspoken secondary 
syphilis ". 
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The clinical records of our casos do not indicate that 
the venereologist's opinion relied on the coincidence of these 
three criteria. The first of Roore's criteria (i) was indeed 
fulfilled in all our cases; but analysis of the sample on the 
basis of the other two yielded the following figures: 
Sore at original site Sore at new site 
l'OTi, 
Seropositive Seronegative Seropos. Seroneg., 
Cited as 
relapse. 28 3 2 0 33 
Cited as 
reinfect- 
ion. 3 2 6 1 12 
Non- 
committal 26 7 3 4 40 
TCY.1'1A.L: 57 12 11 5 85 
Records usually laid emphasis on a history of recent expos- 
ure where oiting a diagnosis of reinfection. It is reasonable to 
assume that the 57 cases whose second lesions appeared at the site 
of the original chancre with coincident positive serum reaction were 
definite cases of muco -cutaneous relapse. Probably, the 12 cases 
which were seronegative when a second lesion appeared on the original 
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site were also muco- cutaneous relapses. Inter alia, hudelo and 
Rabut described 21 such cases in a series of 51. iuiuco- cutaneous 
relapse in the presence of a negative or doubtful serum is thus 
well accredited. The 11 cases whose second lesions were stated 
to have occurred at different sites from the original chancres at 
a time when the serum was positive are more difficult to assess. 
It was clear from the notes of some that the new lesions were suff- 
iciently close to be within the lymphatic watershed of the original 
site, a fact which might well suggest that they were probably muco- 
cutaneous phenomena. On the other hand, records of one or two 
with typical chancres proved to contain T.p. at a site well away 
from. the original chancre and associated with enlargement of lymph 
glands other than those stated to be enlarged in the original in- 
fection cite a doubtful serum reaction. It is conceivable that 
such cases were, in fact, reinfections. Of the five remaining 
cases, none fully satisfies the criteria advanced by Moore. ú'ße 
therefore regard them as relapses, and cite further details with 
reference to them in Table II. 
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(E.M.C. = extra -marital coitus) 
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The evidence that the second sore differed significantly 
in respect of site from the initial chancre is poor in cases 1, 
2 and 4. In case 3 the new lesion was apparently still within 
the lymphatic watershed of the initial chancre. Case 5 is the 
only one in which a negative serum reaction in the presence of 
the second sore was observed to have become positive before 
further treatment was instituted. Unfortunately, dark ground 
examination was not done until the sore had been present for one 
month. It was then negative on three occasions. In no case 
was there evidence that 'repeat' blood tests had been used to 
confirm routine tests. 
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4. CALCULATIOIJ OF :fd7I:LAYB HAT.t;S. 
Al]. time periods date from the end of the course of 
treatment. In what follows, the assumption is that we have 
sorted our data to exhibit: 
(a) numbers of seronegative individuals (xm_l) still 
under observation at the beginning of the mth 
month from date of certification; 
(b) ditto (xm) still remaining under observation at 
the end of the mth month; 
(c) relapses (ym) during the mth month; 
(d) defaulters (dm) i.e. individuals who have ceased 
to be under observation during the mth month. 
The last item is evidently deducible from the others 
by the relation; 
m = xm_l xm - ym (i) 
Our problem is to ascertain the chance of relapse 
during the mth month, denoted below as qn1. If there 
were no defaulters, this would be the ratio of relapses 
during the month to se-onegative individuals at the be- 
ginning, i.e. ym =- xm_1 ; but dm defaulters would have 
accounted for an unascertained number (em) of relapses 
during the same period, so that the correct value is 
given by: 
qm = 7m 
zizi -1 
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Our problem is therefore to estimate em. Let 
us suppose that all the dm individuals had ceased to 
be available for further observation on the first day 
of the mth month after reporting for the census record- 
ing xn_1 seronegative individuals at that date. If 
so, en, would be the relapses during the month referable 
to an initial population of dm seronegative individuals, 
i.e. em 
qm = or em = qm dm dm 
In fact, we are entitled to assume that the 
stream of defaulters is steady, the mean time during 
which they were available for observation being 2 a 
month. We may therefore put approximately 
em - 2 qm dm 
It is important to point out that there is only 
one arbitrary assumption in the above relation, that is 
to say, a linear rate of default in the interval. Other- 
wise the relation is exact for the following reason. 
Suppose that we divide the month into a large number (s) 
of intervals in each of which the number of defaulters 
is dm-:, s. At the beginning of each interval the num- 
ber of defaulters is thus the same; but their contri- 
butions to the total (em) of unidentified relapses will 
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be different. The first batch with a month before 
them can contribute to this total qm dm =-- s. The sec- 
ond batch with a residual fraction of a month equivalent 
to (s -l) -?- s can contribute only s -1 qm dm : s2 and 
so on. The best estimate of em is the limiting value 
of the corresponding sum of the contributions of the 
batches when s is indefinitely large, i.e. 
( 
em = Lt qm d m ( 8 + s - 2 
32 
em = 2 gm dm . 
Hence by (i) above 
em- 
_ 
2 (xm-l- xm - ym) . qm 
Likewise by (ii) above 
q 
m 
= Ym + 2qm (xm -1 xm - Ym) 
xm - 1 
2 qm xm-1 = 2Ym + qm xm-1 - qm xm - qm Ym 
qm ( xm-1 + xm + ym) = 2ym 
(iv) 
2ym 
. . gm () -1 + Zni + Ym 
The appropriate computing scheme for the estimation of 
qm is thus: 
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Date by Residual Serolog- Default- qm_ frori (v) 
month seroneg- ical re- ers from 




populati en ( 
xo 
1 xl 
Yl d1 ql 
2 x2 
Y2 d2 q2 
3 x3 
Y3 d3 q3 
Corresponding to qm the relapse rate, the surviv- 
al rate sm showing the chance of remaining negative 
throughout the month m is given by: 
sm = 1 - qm 
The chance of remaining seronegative to the end 
of the mth month from the beginning of the follow -up is 
the combined product 
sr 
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With a computing machine the effort involved in 
extracting the continued product is small; but it is 
not a necessary operation and the two methods of arriv- 
ing at a result should be the same. The second is to 
proceed thus; 
Residual Observed Estimated Cumulative 





Yi + el Y1 + e1 
2 
Y2 Y2 +e2 E (Yr ) 
1 
x2 
Thus the cumulative relapse rate during m months as 
a percentage is; 
yr + er 
xo 
This should be equal to; 
( m. 
100 ( 1 -IL (1 qr) 
) 
in which (1 - qr) = sr of the preceding development. 
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5. PARTICULARS OF TR.uE1T16ENTS. 
Cases which received Penicillin fall into the following 
groups:- 
1. 2.4 mega units of Sodium Penicillin by three- hourly 
intramuscular injections of 40,000 Oxford units over a period of 
*days with no treatment other than local applications of saline 
or occasionally iiusol and other antiseptics to lesions; 
2. 4.0 mega units of Sodium Penicillin given as above but 
for 122 days; 
3. 2.4 mega units of Sodium Penicillin in *days with a 
course of intensive arsenotherapy beginning on the second day of 
Penicillin treatment, viz. íhapharside 0.06 gm. intravenously daily 
for a period of ten days; 
4. 2.4 mega units of Penicillin, 0.4 gn. hapharside and 
1.0 gm. Bismuth given concurrently as above (3) over a period of 
10 days. 
Standard commercial preparations were used. The proportions 
of the different crystalline Penicillins in these preparations are 
not known. 'Long Term' Arsenic cases call for more detailed speci- 
fication. Ostensibly, it was the policy to treat all cases of: 
(a) Primary Syphilis with at least 4 courses of Arsenic and Bismuth 
given concurrently in a twelve -month period, each course consisting 
of 5.85 gm. of N.A.B. and 2.0 gm. of Bismuth; (b) Secondary Syphilis 
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with at least 5 courses of Arsenic and Bismuth. In practice, 
it rarely proved possible to implement this procedure consist- 
ently. In fact, cases in our series treated with apparent 
success received from between 3 -27 gm. N.A.B. and 3 -18 gm. of 
Bismuth over periods varying from 8 -23 months. Documentation 
w.r.t. some cases was poor, only the number of courses being 
stated. Other long -term cases received in addition to N.A.B. 
and Bismuth, two weekly injections of 0.06 gm. Mapharside in 
place of a single injection of O.ti gm. N.A.B. Cases receiving 
Mercurials (3% of all) were rejected from the pool of data. The 
composition of the group was as follows:- 
s 
(437 eases) 
N.A.B. No. of courses and dosage known 61 
Bi. 
N.A.B. 
Bi, No. of courses aad dosarre known 16.6 
Tvtaphars ide 
N.A.B. 
Bi. No. of courses known. Dosage 
Mapharside not stated 
22.4 
100.0 
Cases which received Mapharside and oases for which 
treatment dosage was not fully stated make up more than a third 
of the total material available. So it was decided to retain 
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them. In specifying the equivalent dosage of N.A.B. received 
by such cases, wo equate 0.12 gm. of Mapharside to 0.6 gm. N.A.B. 
and add the quantity of N.A.B. so computed to the actual amount 
of N.A.B. received. 
TABLE III 
Mean value in grams for N.A.B. and Bismuth 
and mean value in months for period of 
Treatment in cases receiving four courses 














Prim: Sero: 36 
66 
38 
19.5 I 0.6 
19.0 * 0.5 
19.0 t 0.2 
9.3 t 1.3 
9.5 ± 0.4 
9.7 t 0.5 
13.2 I 0.5 
13.7 ± 0.6 





From analysis (Table III) of dosage given in four courses 
to cases with reference to which the-information was available, it 
was possible to distribute the L.T.A. cases among 2 groups: 
(i) Group A cases receiving more than 1a0gn, of N.A.B. or, where 
dosage was not stated, four or more courses of Arsenic and Bismuth; 
50. 
(ii) Group B cases receiving either loss than 19.0 gm. of arsenic 
or less than four courses of Arsenic and Bismuth. Tables IV A, 
and B show that the only obviously significant difference between 
these groups is the dosage of arsenic:- 
TABLE IV A 
Analysis of cases receiving more than 

















Neg : 28 22 .1 . 0.9 9.5 t 0.6 14.1 ± 0.9 
Prim: Sero: 
--- -15-6-i 50 22.1 ±0.4 9.7 {0.2 13.71 0.4 
Secondary 52 22.3 t 0.3 10.2 ± 0.4 14.7 ± 0.4 
TABLE IV B 
Analysis of cases receiving less than 
















Prim :Sero: 75 13.0 ± 0.5 8.7 t 0.2 12.2 ± 0.4 
Neg: - 
Prim :Sero: 81 14.4 ± 0.3 9.8 t 0.2 14.1 ± 0.4 +ros : 
Secondary: 53 13.4 ± 0.6 9.5 ± 0.4 14.0 ± 0.4 
51. 
As a result of this analysis 79 cases receiving between 
4 and 6 courses of Arsenic and Bismuth were added to Group A 
whilst 19 cases receiving between 2 and 3 courses only were added 
to Group B. :CIO significant departures from these mean values 
occurred among cases which were known to have relapsed in the two 
groups. Analysis of Group A and B cases with reference to the 
incidence of jaundice revealed a highly significant difference 
(Table V) between the two groups. This was, of course, the prime 
reason for the lower average Arsenic dose in Group B. The inci- 
dence of dermatitis was also higher in this Group though it was a 
minor contributory factor in lowering the Arsenic dosage for the 
group. Differences with reference to incidence of jaundice be- 
tween the three subdivisions within. each group are not statisti- 
cally significant, though examination of a largor series of cases 
has shown that maximum susceptibility to jaundice occurs during 
the very early stage of Syphilis. 
TABL V. já JAU DICBD 
No. of Primary Primary Secondary 
Cases hero -NeP: ero-Pos: 
Group A 209 15.2 27.8 20.5 
Group B 228 54.3 60.6 45.2 
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A group of 'Long -Term' Arsenic cases subsequently treated 
with Penicillin started treatment on a purely 'Long-Term' Arsenic 
basis, but after a variable interval arsenotherapy was stopped; 
and they were given a routine course of Penicillin 2.4 Lega units 
in Ti days. Table VI shows the mean values for Arsenic and Bis- 
muth received prior to Penicillin therapy and the mean period over 
which therapy (including Penicillin) took place. 
TA3LW VI 
Mean quantities of Arsenic and Bismuth 
received prior to Penicillin Therms. 
No. Mean dose Mean dose Mean duration 
Diagnosis of (N.A.B. (Bismuth of treatment 





26 7.7 t 0.6 4.1 t 0.4 6.4 ± 0.8 
Prim,:aero: 39 7.1 ± 0.5 4.1 t 0.5 7.0 } 0.7 
Pos: 
Seconday: 26 7.9 + 0.7 4.8 ± 0.6 7.1 ± 0.1 
It can be seen that similar amounts of N.A.B. and Bismuth 
were given throughout and that the period between the beginning of 
arsenotherapy and the end of Penicillin injections was not unduly 
variable. Amongst cases which are known to have relapsed there 
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were no significant departures from the mean values given above. 
The three divisions into Primary, Sero- negative, Primary Sero - 
positive and Secondary cases refers to the condition at the in- 
ception of Arsenotherapy. By the time Penicillin therapy began 
most of the initially Sero- positive cases had become Sero -negative. 
Table VII indicates the proportion of cases in which Sero -reversal 
had taken place, those in which the serum test was still positive 
and those who had not had a recent test. 













Sero -Nei.: 25 100 0.0 0.0 
Prima 
Sero -Pos: 38 64.1 10.3 25.6 
Secondär 26 80.8 11.5 7.7 
Cases, which received Short -Term Arsenic Therapy fell into 
two groups. The first group comprised cases treated by daily in- 
travenous injections of Mapharside of 0.06 gm. and intramuscular 
injection of Bismuth over a period of 20 days. On inspection the 
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cases consistently received a total of 2.0 gm. Bismuth and the 
treatment period was 20 days with exceptional and minor variations 
(e.g. ± 0.2 gm. Bismuth and ± 1 day respectively). Mapharside 
dosage varied between 1.2 gm. and 1.6 gm. for the course. Table 
VIII shows however, that the mean dosage was 1.3 gm:- 
TABLE VIII. 
Diagnosis No. of Mean dose 
Oases Mapharside 
(gm) 
PrimaJSero: Nec: 32 1.31 
Primary Sero: Pos: 38 1.30 
Secondary 42 1.29 
The second group comprised only about 40 cases treated 
by seam- intensive courses of Mapharside, or Neohalarsen, and 
Bismuth over a minimum period of 30 days. The variability of 
dosage and treatment period were, however, too great to allow of 
standardisation in such a small group of cases. W'e therefore 
present the relapse rates for the 20 -day treatment group only. 
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6. RúSULi'S . 
Appendix 1 cites crude figures with reference to relapses, 
and failures and doubtful cases; and Appendix 2 cites cases re- 
maining at the end of specified intervals after end of treatment. 
Table IX shows cumulative relapse rates at the end of 6 and 12 
months for the different treatments. With regard to some, it was 
possible to follow sufficient cases for 18 months. Figures can 
be regarded only as trends owing to the small size of some samples. 
All failures as defined above have been excluded. It is evident 
that the Penicillin courses are comparatively unsuccessful except 
when following Long -Term Arsenic. The two L.T.A. schemes are 
apparently the most efficient particularly for treatment of Primary 
Syphilis and in contrast to other forms of therapy are the most 
successful treatments of Secondary Syphicis. Short -term Arseno- 
therapy takes an intermediate position. It, is interesting to 
note the comparative relapse rates of S.T.A. (Mapharside 1.3 gm. 
and Bismuth 2.0 gm) with: (a) Penicillin 2.4 hu + Mapharside 0.6 
gm., and (b) Penicillin 2.4 Mu + Mapharside 0.4 gm. + Bismuth 
1.0 gm. 
Duration of treatment was much the same for each of these 
therapies. The relapse rates of S.T.A. are consistently smaller 
than those of either form of combined therapy. The least differ- 
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ence occurred in cases of Seropositive Primary and in cases of 
Secondary Syphilis between S.T.A. and Pen: 2.4 Mu and Mapharside 
0.6 gm. Since Penicillin alone, in the two dosage schemes in- 
vestigated, is least efficacious of all, these relapse rates sugg- 
est that Penicillin may in some way mitigate the effect of Arsenic 
on Treponema+pallidum. It is however, necessary to point out 
that the dosage of Mapharside received by the S.T.A. group was at 
least twice as great as that given to the Penicillin cases. 
Our data sustain the accepted conclusion that the prognosis 
for arsenotherapy is less favourable if treatment does not start 
until the sero -positive primary stage. Contrary to results re- 
ported by Moore and others they would also suggest that the prog- 
nosis for sero- positive primary oases is better than that for 
secondary cases. Our results do not suggest any consistent diff- 
erences in these respects with regard to Penicillin therapy. Al- 
though attenuation of our material awing to the introduction of 
Penicillin shortly before demobilisation compels us to state only 
guarded conclusions with respect to the long -term prognosis of 
Penicillin therapy, the picture disclosed by Figure 1 suggests 
that the risk of relapse among cases treated in the primary stage 
of each is a limiting value of about 144 within the first twelve 
months. 
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CUMULATIVE PERCENTAGE RELAPSE RATES 
2 .4 MEGA UNITS PENICILLIN 
j Z 3 4 5 6 7 8 9 IÓ Ì I 
O Primary Scro- Negative 
II Primary Scro- Positive 
A Secondary 
12 13 14 15 16 17 
MONTHS AFTER END OF INITIAL TREATMENT 
18 
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Our definition excludes the occurrence of failures among 
Sero- negative Primary cases. Table X shows an analysis of those 
cases remaining ero-positive for four or more months. Penicil7.in 
has a comparatively higher rate of failure among Sero -positive 
Primary cases but among Secondary cases, particularly when combined 
with Mapharside, compares not unfavourably with S.T.A. and the 
smaller dosage group (B) of L.T.A. For most treatments the prog- 
nosis in this respect of secondary cases is less favourable than 
the prognosis of primary cases. 
TABLE X. ANALYSIS OF TREATMENT FAILURE CASES. 
Percentage of treatment failure cases (defined as cases remain- 
ing persistently sero-- positive for four months or more after 
treatment) as a percentage of total numbers of cases (within 
each treatment) . 
PEN: PEN: PEN : 2.4 PEN : 2.4 LTA LTA LTA STA 
2.4Mu 4.ONu Mu and IvIu Maph: 7gm (A) (B) 1.3 gm. 
Maph: 0.4 gm. & 22 14 Bi 





gm gm 2.0 gm. 





7.43.2 3.43.8 2.542.5 2.842.8 0.0 0.0 5.040.0 10.746.0 
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SUZvIIvitRX . 
Relapse rates during a 12 -month period of cases of Early 
Syphilis respectively treated with eight different therapies are 
contrasted and disclose the following conclusions: 
1. Long -terre Arsenic in a mean dosage of 22 gm. N.A.B. 
given in four or more courses proved to be the most effective 
therapy for all forms of Early Syphilis. In dosages averaging 
14 gm. in fewer than four courses, it was the next most efficac- 
ious. 
2. For Primary cases in the doses, and for the period, 
specified in the test Penicillin alone was inferior to either 
long -term or short -term Arsenotherapy both with respect to prog- 
nosis of relapse and resistance to treatment. 
3. The data of this enquiry give no conclusive indicat- 
ions of synergism with reference to simultaneous use of Penicillin 
and Arsenicals with Bismuth, being suggestive, if at all, of the 
reverse. 
4. Though the data recorded admittedly antedate recog- 
nition of the importance of the K- fraction, the results at least 
emphasize the need for long -term follow -up before replacing arseno- 
therapy by Penicillin. 
5. On the other hand, it is necessary to admit the possi- 
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bility that greater frequency and/or duration of Penicillin 
treatment in contradistinction to greater aggregate dosage might 
reverse the unfavourable verdict which our data compel us to 
record. 
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APPENDIX 1. 
The relative distribution of relapses and treatment failures in the various treatment 
groups and their subdivision into primary sero-negative, primary sero -positive and 
secondary cases. Space does not permit of indication of the relationships of relapses 
to time intervals after treatment. Crude figures. 








































PEN: 4 11 1 3 15 3 1 4 0 8 4 2 5 '7 
PEN: 4.0 5 0 1 1 0 0 0 1 2 1 0 0 1 
PEN: & 
IMIAPH : 10 1 2 5 1 . 3 0 1 3 0 0 0 2 
PEN : MAPH: 
& Bi. 5 0 1 6 1 1 3 1 6 1 0 0 2 
LTA & PEST 2 0 0 2 0 0 0 0 0 3 1 0 0 
LTA (A) 0 0 0 0 1 0 . 0 0 0 0 6 0 0 
LTA (B) 0 0 0 1 1 0 0 0 0 4 0 2 0 
STA 0 0 0 2 2 2 -0 0 1 5 0 2 5 
TOTAL: 33 2 7 32 9 7 7 3 20 18 9 9 17 
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APPENDIX 2. 
Numbers of cases in each treatment group (sub- divided into primary sero- negative, 
primary sero- positive and secondary) and the numbers of cases remaining under surveillance 
after six and twelve months. 
It will be noted that relatively small numbers of cases in the LTA, LTA +PEN and STA 























treated 114 57 108 105 25 44 75 32 
Remaining 
6/12 80 20 30 51 23 30 64 31 
Remaining 





treated 163 41 110 89 38 84 84 38 
Remaining 
6/12 122 14 31 42 31 64 63 35 
Remaining 





treated 118 28 53 48 26 67 46 42 
Remaining 
6/12 86 8 25 20 19 48 36 39 
Remaining 
12/12 32 0 5 4 9 26 20 28 
395 126 271 242 89 195 205 112 1635 
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PART III. THE USE OF PALUD AINE FOR B.T . M L RIA RELISES. 
An enquiry to compare Mepacrine therapy and quinine and 
Pamaquin therapy was reported in the Bulletin of Army Health 
Statistics (1st Series 11th Issue) in September 1945. By arrange- 
ment with Consulting Physician a further comparative trial was 
arranged to test Paludrine. The writer took responsibility for 
the analysis of the data and design of the records. The clinical 
details of diagnosis and treatment were carried our by Major R.D.C. 
Johnstone, R.A.M.C. Medical Specialist at Colchester Military Hosp- 
ital, who also dealt with follow -up of cases during the six months 
after discharge from Hospital. The three methods of treatment 
under consideration were: 
A. quinine gr. x and Pamaquin 100 mgn. three times 
a day for 10 days. 
B. Paludrine (M.4888) 25 mgm. twice daily for 10 days. 
C. Paludrine (11.4888) 250 mgm. twice daily for 10 days. 
All cases in the series were male patients admitted to the 
Colchester Military Hospital in the normal routine and were unsel- 
ected except in so far as they were proved to have B.T. Malaria by 
positive blood smear. Each treatment was administered to every 
third patient in order of diagnosis; and no man was selected for 
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a particular treatment because the physician considered that more 
suitable for him. All were treated alike in the ward; and no dis- 
was permitted to allow patients to know what drugs they 
were being given. 
The previous enquiry confirmed an already recognised period- 
icity of relapse with a major peak in the second and a minor peak 
in the ninth month. To establish a high order of therapeutic eff- 
icacy for a new treatment, it would therefore be necessary to follow 
the history of a group of patients through a period of at least one 
year. On the other hand, the validation of a negative finding needs 
110 such exacting test. That relapses occur in excessive propor- 
tions during the early months after treatment suffices to dispose 
of the claim that a treatment is highly efficacious. It happens 
that observations on the results of Paludrine administration during 
the first six months satisfy this criterion. To provide an answer 
to the question which prompted this enquiry it has not therefore 
been necessary to await results of a more protracted trial. Follow - 
up was by written questionnaire and where ambiguous replies were 
given, a further letter was sent to elucidate the query. Of 322 
cases who received it, satisfactory information was received from 
all but 5 cases. Information with reference to the others left 
no reason to doubt whether there had been a recurrence of the dis- 
ease or whether the patient had taken therapeutic or suppressive 
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medications liable or likely to postpone relapse. 
These 322 cases were thus distributed with respect to 
treatment: 
A. 107 - including 3 doubtful. 
B. 108 - " 1 ,' 
C. 107 - " 1 u 
322 
Analysis of the results 6, months after the end of treatment 
(Table I) showed that the Relapse Rate following the standard treat- 
ment with Q.uinine and iamaquin was significantly less than the 
relapse rate for either of the two groups receiving Paludrine. 
There was no significant difference with respect to relapse rates 
of patients respectively given large or small doses of Paludrine 
over a period of ten days. 
TABLE I . 
Rl;l,b&Si RAJ 6 I4I0IJTIi,`á x'TliI3. Ti3i:;ATIei;&NT 
Schema Total Cases ¡á Doubtful ¡á Relapses Differences 
A l07 2.8 19.6 ± 3.8 
25.8 ± 6.1 
108 0.9 45.4 ± 4.8 29.0 6.1 
3.2 ± 6.8 
C 107 0.9 48.6 t 4.8 
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The relapse rate for Quinine and Pamaquin in Table I com- 
pares unfavourably with the rate of 10.370 after five months in the 
earlier series referred to above; and therefore calls for comment. 
The extra month of the present follow -up can account for few addit- 
ional cases; and the difference is at least in part explicable, if 
we pay due regard to the different methods of follow -up employed in 
the two enquiries. In the present series the personal questionn- 
aire by the physician evoked a definite reply from each patient. 
The method of collecting material for the earlier enquiry gave a 
reliable comparison between the two groups of cases within the series; 
but provided no firm basis for absolute rates. Hence the results 
are not comparable with those of any other series. 
With a view to assessing the effect of treatment given early 
or late in relation to onset of symptoms, the moan duration in days 
from onset of symptoms to start of treatment was determined for each 
group. That of Group A was somewhat less than that of B or C, the 
difference being significant. Among those who received Quinine and 
Pamaquin, a relatively high proportion therefore received it (Table 
II) at an early stage after the onset of the attack. This might 
conceivably introduce a bias into comparison of figures shown in 
Table I. Accordingly Table II shows relapse rates for different 
time intervals between onset of symptoms and start of treatment. 
It omits cases treated during the first 24 hours (one case in Group 
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A, two in B, one in C) and certain cases where the time intervals 
were uncertain. In conformity with the results of a more refined 
breakdown of relapse rates with reference to the time interval 
under discussion the grosser comparison which Table II exhibits 
demonstrates that Group A consistently had lower relapse rates than 
Groups B or C treated during a comparable period after onset of 
symptoms. 
TABI3 II 
RI;1AT l' Oiü OF TEL T IIJL ; IIV'i'r;AVAI.+S BLTLE11 UId:iET UF 
S YhPT 0i4 AM) STARTING TRLATTd.iEIZ . 
Duration 
% ' A S E S $ R L L A P S E S 
Scheme A Scheme B Scheme C Schema A Schema B Scheme C 
(102) (101) (102) 
24-48 hours 12.7 6.9 6.9 23,1 28.6 71.4 
49 -96 hours 51.0 39.6 34.3 19.2 50.0 54.3 
97 -144 hrs. 24.5 33.7 35.3 16.0 50.0 41.7 
Over 144 11.8 19.8 23.5 16.7 35.0 45.8 
100.0 100.0 100.0 
In so far as the figures of Table II suggest that there is any 
relation between therapeutic efficacy and what time elapses from onset 
of the attack to start of treatment those specifically referable to 
Group A might encourage the suspicion that too early treatment favours 
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a high relapse rate. If so, the higher proportion of Group A 
patients treated during the first interval would bias the result 
of an unduly law estimate of the relative efficacy of quinine and 
Pamaquin. An alternative analysis of the same data as shown be- 
low reinforces this suggestion. Though the differences are not 
statistically significant, they point to an issue worthy of further 
enquiry and of consideration in the design of any future thera- 
peutic trial on anti - malarial drugs. 
25 - 48 hours 23.1% ± 12.2 
49 - 72 hours 21.1% ± 9.6 
73 - 96 hours 18.2% ± 6.8 
97 -120 hours 9.5% ± 6.8 
One other possible source of bias calls for comment, i.e. 
the relation of numbers of previous attacks to the efficaoj of any 
particular treatment. Table III discloses no indication that 
cases with a history of four or more previous relapses are more 
likely to relapse after treatment than cases with a history of 
fewer than four previous relapses. 
TABLE III 
and i'4,maquxn Casesi 
RB:LA.TIUTÚF REI.APSE: RATSS TO TNNíBi;RS OF P'tüNIUliS 
ATTACKS OF B.T. Pla7.ARIA. 
3 or fewer attacks 
4 or more attacks 
No. of Cases % Relapse Difference 
29 17.2 




1. During the first six months after treatment between 
45:, of B.T. Malaria relapses relapsed again after treatment with 
25 mg. of Paludrine, twice daily for 10 days and 49% similarly 
relapsed when. treated with 250 mg. doses. 
2. The corresponding relapse rate for a control group 
treated with Ctuinine and Pamaquin was loss than 20`'jó. 
3. In any future therapeutic trial of anti- malarial 
drugs, it might be profitable to direct attention to the possible 
relation between the efficacy of a treatment and the interval to 
its initiation from the onset of symptoms. 
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PART IV. TREATMENT OF ITVTLRNAL DNNAIVGEIuigPd'l' UF TEE KNEE. 
1. INTRODUCTION. 
Among men in the Army I.D.K. ranks as a major source of 
wastage alike with respect to incidence, man -days lost to service 
and invalidings. From the figures available for 1943 it appears 
that the absolute incidence in Britain was about 0.3%. The relative 
morbidity rate was 1.7% and the relative wastage rate 4.1/. That is 
to say I.D.K. accounted for over 4% of man -days lost to service on 
account of sickness. In the same year it accounted for 0.5% of 
discharges on account of sickness from the Army as a whole. Clearly, 
it is therefore important to assess circumstances contributory to 
its occurrence and what measure of success attends its treatment. 
Such is the aim of what follows. 
The ensuing analysis refers to a nominal roll of Military 
O.Rs. admitted to hospital in Britain during the 12 -month period 
August 1943 - July 1944. The size of the sample was 777 of whom 
50 were admitted twice within this period. During their Army ser- 
vice up to July 31st 1944, some of these 777 cases had been prev- 
iously hospitalised for the same complaint, and as the figures below 
show, the 777 individuals studied thus correspond to a grand total 
of 967 admissions to hospital; 
71. 
Admissions per Individual Individuals Man- admissions 
1 627 627 
2 118 236 
3 25 75 
4 6 24 
5 1 5 
Total:- 777 967 
2. DURHTION OF TRhiti,TiuLNT IN DTI-11'101W MEDICAL UNITS. 
Two striking features of wastage with respect to I.D.K. 
exposed in the ensuing table are: 
(a) the protracted period between hospital discharge 
and return to unit of cases whether treated 
by operation or not; 
(b) the more protracted stay of cases in E.M.S. as 
compared with Military hospital. 
As regards (b) it is noticeable that the longer duration 
of hospital treatment among patients who underwent operation in 
L.M.S. Hospitals is not associated with longer convalescence. 
Analysis of Days away from Unit, Mean days per man 
WITHOUT OPLR4TION (35.4 (7Q) WITH OPERATION (64.6j0) 
E.M.S. Military Hospital E.M.S. Military Hospital 
Hospital 31.2 18.4 61.6 42.9 
Con. Home 28.9 32.7 39.7 42.1 
Con.Depot 43.7 40.9 51.2 51.1 
Total 
Duration. 54.7 29.7 120.5 104.8 
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Owing to incompleteness of information and the fact that 
all patients do not necessarily go through Convalescent Homes and 
Depots, these figures are calculated from all records with re- 
liable data, and the individual items in each series are not nec- 
essarily based on the same cases or the same number of cases. Com- 
parison of the two types of hospital discloses a discrepancy with 
respect to length of stay in hospital and total duration of absence 
from duty of men treated without operation. As regards the former, 
the difference between patients in E.M.S. and patients in Military 
Hospitals is 12.8 days. As regards the latter the difference is 
25 days. Duration of stay in Convalescent Homes and Depots is 
approximately equal for both classes of patients. The discrepancy 
is due to transference of fewer cases from Military Hospitals to the 
Y -list and hence fewer to Convalescent Depots. This is demonstrable 
by contrasting: (a) mean duration of stay in the two types of hosp- 
ital (Military 18.4 days, E.M.S. 31.2 days); .(b) the proportion of 
patients respectively sent from each type of hospital to Convalescent 
Depots (Military 13.8jó, E.M.S. 42.370). Longer stay in :C.M.S. Hosp- 
itals might also be attributable in part to delay of operation or 
longer conservative treatment in D.M.Z. as compared with Military 
Hospitals, of which a greater proportion have out -patient departments 
for preliminary examination and surveillance. The figures shown do 
not conspicuously confirm this supposition with reference to cases 
subjected to operation. 
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Days in Hospital before hEA1`1 DAYS l' it C1EF 
operation E.Iai.S. (286) uïil.Hospital (176) 
21 or less 7.1 (237) 6.3 (148) 
Over 21 48.4 ( 49) 39.2 ( 28) 
3. CRITERIA. OF 1 FFIC4CY. 
Of statistical indications with respect to success of 
treatment three call for special comment: (a) indications of 
previous operation; (b) discharge from the service on medical 
grounds; (c) change of medical category. AZ regards (a) it is 
noteworthy that only 14 out of 500 menisci removed were remnants 
(11 posterior horns and 3 rims) of previous men.iscectomies. 
Though I.D.Y. is a major source of man -days lost to service it 
does not in fact make a considerable contribution to total wast- 
age, i.e. discharge under category L, and such was the disposal 
of only 1.8jó of the sample dealt with. Change of medical category 
(if stated) of cases treated or not treated surgically might thus 
be regarded as the most instructive indication of its efficacy at 
our disposal; such information, is available with respect to the 
patient at the time of admission to hospital and return to unit 
after discharge from hospital or Convalescent Depot. The follow- 
ing table refers to cases with respect to which we have information 
concerning medical category both at admission and on discharge. 
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WITH OYLaAT TVL Ti tATitiii;iVT 
No. of ¡o without lowering 
Oases of medical category 
WITHOUT QPitATIVlI; TiZ.,TTuiEIV.T 
No. of % without lowering 







53.1 ± 8.8 
70.0 ± 8.4 




52.0 -r 5.7 
44.8 ± 9.2 
50.0 ± 4.9 
None of the differences recorded in this table is significant. 
Accordingly, there is no indication that conservative treatment has a 
bad prognosis, but this may merely be attributable to the fact that 
cases not recommended for surgical treatment were the less severe 
ones. 
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PART V. SU1iNH'ri DRUGS AhD P'r:Iti I C I LLIiy FUR THE 
TI '1.'IVEIJ'1.' 0V GUIJURRRUi:lA. 
1. DOCUM.SHT,dRY SÜUxC;úS . 
What follows refers to cases (Yale Other Ranks) of 
Gonorrhoea treated in Hospitals in Britain between January 1943 
and September 1945. Information was available with respect to 
diagnosis, age, duration of stay in hospital, courses of treatment 
by dato, presence or absence of relapse and interval from completion 
of stay in hospital to day of subsequent admission, where relevant, 
and previous history with respect to the disease. 
2. CRITJIRA OF THSRA.OSUTIG EFFICACY. 
Three criteria are practicable: 
(a) response to a single course of treatment: 
(b) relapse rate: 
(o) duration of stay in medical unit. 
(a) Response to a single course of treatment. A common 
difficulty of enquiries of this sort arises from the fact that the 
physician's primary concern is to cure the patient by any means at 
his disposal rather than conform to the requirements of a controlled 
experiment. Hence many patients receive more than one method of 
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treatment, concurrently or successively. For this reason it has 
been convenient to classify the records with respect to treatment 
in two major groups: 
(A) those who received initially a single course of:- 
(a) penicillin, (b) sulphathiazole, (c) sulphapyridine;. 
(B) those who received treatment with one or other of the 
above and simultaneous irrigation with either iGVnO4 
or HgOCN. 
The operative word in (A) is initially, because any case which 
fails to respond to a single course of therapy normally receives add- 
itional treatment. This circumstance permits us to refine our crit- 
erion of success. ìince no case is ordinarily discharged from hosp- 
ital without a clean bill, the use of a single method or simultaneous 
combination of two methods followed by no other is a sufficient indi- 
cation that such a course is successful. Conversely, recourse to 
additional courses after a lapse of time sufficient to assess the 
value of the primary treatment is one admissible criterion of failure. 
From this it follows that our data provide no olear guidance 
with respect to the efficacy of a combination of successive, as opp- 
osed to simultaneous therapies. Individuals who receive a subsequent 
course of treatment may be highly selected, both because they are 
patients who fail to respond to a single method and because the 
Venereologist will exercise his clinical judgment to prescribe the 
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choice of further treatment.' 
(b) Holase Hate. As a  of efficacy on its own 
merits the relapso rate, here defined as readmission within 60 
days, calls for no comment; but it is possible to apply a more 
exacting yardstick of cure than the one specified in preceding 
remarks by combining information both with respect to failure to 
respond to a single (unitary or composite) course of treatment, 
and to recurrence after discharge from hospital. What we here 
designate a permanent cure therefore signifies a case: (a) com- 
pleted without recourse to subsequent treatment: (b) not admitted 
again to hospital within the arbitrary period of 2 months, delim- 
ited with due regard to the danger of confusing a genuine relapse 
with a reinfection. 
(c) Duration of stay in Medical Unit. 
} 
With due regard 
to variation arising from administrative instructions, duration 
of stay may be a useful yardstick of therapeutic efficacy if a 
condition involves protracted hospitalisation; but the inevitable 
delays involved in transfers of patients to and from medical units 
exclude any reliance upon it, when the total time spent in hospital 
is about a week. lierce we should not expect any conspicuous diff- 




DURATION ÙF STAY IN HOSPITAï, - SIPtIPLW ':I.':lZ.c+:A'.rïvïk.:1V'.i'S.. 
No. of Gases I'úean. Days Differences 
P1;NICILI.,IN 215 6.8 ± 0.8 
2.0 ± 1.2 
SULP HLTHIAZí1LE 358 8.8 
± 0.9 3.0 ± 0.8 
1.0 ± 0.9 
SULPHAPYRIDINIJ 113 9.8 ± 0.2 
Data from another source records interval between admissions 
to forward medical units and cessation of urethral discharge. These 
disclose a striking difference, and hence show how unavoidable delays 
inherent in hospital administration. attentuate such figures as those 
in Table II. The relevant ratios exhibited below show that simple 
treatment with penicillin excels simple treatment with sulpha drugs 
with respect to the rapidity of the cure as well as the proportion 
of successes. 
TABLI:1 12. 
DURATI ON OF Tïtl",ATi46ld T IN FORWARD UNITS. 
No. of Cases IZean Days Differences 
PENICILLIN (alone) 598 1.9 ± 0.004 
SULPHA DRUGS (alone) 266 5.8 ± 0.017 
3.9 ± 0.006. 
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PART VI. l'EïdIC1LLIN T:kiLATMSNT OF I16PLTIGO. 
The hospital records of 1031 soldiers suffering from 
Impetigo who were treated in Britain during 1943 -44 were examined 
to compare different methods of treatment: of these methods the 
documents admit a threefold classification as follows: 
(i) Over half (52.2 %), here denoted Group 0, received 
only lotions, ointments, compresses and drugs 
other than those of the sulpha group: 
(ii) A group (S) of 425 cases (41.2(/0) received sulpha 
drugs, e.g. microcrystalline sulphathiazole 
and sulphanilamide powder: 
(iii) A small residual group (P) of 68 (6.6 %) received 
penicillin. 
The clinical notes indicated that some of the cases had at some 
time previously suffered from the disease. Over 80% were apparent- 
ly new. As shown below, the proportions of new cases in the three 
groups were not significantly different: 
Group O. Group S. 
New Cases 80.7 t 1.7 83.7 ± 1.8 
.9.E2'12.1. 
79.4 ± 4.9 
Relapses 19.3 16.3, 20.6 
TOTAL: 100.0 100.0 100.0 
(538) (425) (68) 
In the absence of more speoif io indications provided by 
clinical notes on the case record, Army medical documents furnish 
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the following yardsticks for the assessment of therapeutic 
procedures: 
(a) Mortality rates; 
(b) Relapse rates; 
(c) Rate of subsequent discharge from the 
Service on medical grounds; 
(d) Supervening diseases and / or complications; 
(e) duration of hospitalisation before being 
returned to Unit; 
(f) Subsequent medical recategorisation. 
It is rarely practicable to apply all of the above. If a 
disease a serious source of total wastage neither (a) nor 
(c) is practicable. Impetigo is not fatal. It is rarely a suff- 
icient reason for discharge from the Army; and is not commonly 
associated with supervening disease or characteristic complications. 
Administrative recommendations to ensure reliable information res- 
pecting medical recategorisation have not yet taken effect. We 
are thus left with (b) and (e). Though figures cited above sugg- 
est that the relapse rate is not negligible, relapses which occur 
in the Army are trivial. Our only practicable yardstick is there- 
fore (e). Mean duration of stay is admittedly a criterion liable 
to bias resulting from administrative considerations which govern 
hospital policy or disposal; but if the classes of a large sample 
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are contemporaneous, the association of shorter mean duration 
with a given treatment constitutes a strong prima facie case for 
its greater intrinsic efficacy. The following figures exhibit 
the mean duration (days) of hospitalisation for each of the 3 
groups taken as a whole (i.e. including both new cases and cases 
with a previous history of the disease): 
Mean Duration Difference 
of Stay. 
Group 0 (neither sulpha drugs 
nor penicillin) ... 19.5 ± 0.68 
Groups (sulpha drugs) ... 15.7 ± 0.50 
Group P (penicillin) ... 12.1 ± 0.77 
3.8 -r 0.84 
3.ö ± 0.92 
Each of the differences recorded above is significant, i.e. 
(a) duration of stay with respect to penicillin treatment is signif- 
icantly shorter than with respect to treatment with sulpha drugs; 
(b) duration of stay with respect to treatment with sulpha drugs is 
significantly shorter than with respect to treatment with neither 
sulpha drugs nor with penicillin. Though the differences as re- 
gards the composition of the sample, in so far as the proportion of 
putatively new cases might bias the result, are not statistically 
significant, the issue calls for a check. A similar analysis of 
new cases only yields the following results: 
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Mean Duration Difference No. of 
of Stáy_. Cases 
Group 0 18.3 0.7 434 
3.1 ± 0.86 
Group S 15.2 ± 0.5 356 
3.4 ± 0.86 
Group P 11.8 ± 0.7 54 
A similar analysis of the chronic class yields the 
following: 
Mean Duration Difference No. of 
of Stay. Cases 
Group 0 ... 24.5 ± 2.0 104 
6.4 ± 2.4 
Group S ... 18.1 ± 1.3 69 
4.7 ± 2.8 
Group P ... 13.4 ± 2.5 14 
All the differences in the last two sets of figures tally, 
and all are statistically significant except the difference between 
the S and P relapses. The dubious significance of the latter 
difference is sufficiently explicable on account of the very small 
number of cases in the P group. However the difference with res- 
pect to mean duration of stay after penicillin treatment of the 
chronic cases (denoted as relapses above) and treatment of such in- 
dividuals with neither penicillin nor sulpha drugs is highly signi- 
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f icant, being 11.1 ± 3.2. 
As we might well expect, the preceding breakdown suggests 
that chronic cases are more recalcitrant to treatment. It is there- 
fore fitting to exhibit the two sets of figures in a different way: 
New Cases Chronic Cases Difference 
Group 0 ... 18.3 t 0.7 24.5 ± 2.0 6.2 ± 2.1 
Group S ... 15.2 ± 0.5 18.1 ± 1.3 2.9 ± 1.4 
Group P ... 11.8 ± Ù.7 13.4 ± 2.5 1.6 ± 2.6 
Preceding remarks have drawn attention to one disadvantage 
of using duration of stay as the only practicable yardstick of thera- 
peutic efficacy, in so far as it is liable to bias arising out of 
differences of administrative procedure. it is therefore important 
to take cognizance of the fact that some patients received treatment 
in L.M.S., others in military hospitals. This consideration is 
particularly pertinent, because the mean duration of stay for skin 
diseases is somewhat greater in the former than in the latter. 
Hence differential distribution with respect to the two groups of 
hospital in groups subjected to different methods of treatment might 
well account for the different results reoorded above, if the propor- 
tionate contribution of hospitals was greater for treatment 
groups with longer duration of stay. Analysis of the sample from 
this point of view reveals that this is so. Fortunately, the diff- 
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iculty is easy to short -circuit because the majority of cases dealt 
with received treatment in military hospitals, and these groups alone 
suffice to provide a homogeneous sample large enough to act as a 
check on conclusions seemingly justified by figures exhibited in pre- 
ceding tables. The figures below refer to fresh infections treated 
only in military hospitals: 
Fresh Infection - Military Hospitals. 
Group 0 
Mean Duration Difference of No. of Cases 
of staff means 
312 ... 17.69 ± 0.73 
3.18 ± 0.93 
Group S ... 14.51 t 0.57 277 
2.97 ± 0.94 
Group P ... 11.54 t 0.74 48 
A similar analysis of chronic cases treated in military 
hospitals yields the following results; 
Chronic Infections - Military Hospitals. 
Group 0 ... 24.5 ± 2.27 87 
5.9 2.6 
Group S ... 18.6 ± 1.38 59 
5.6 ± 2.6 
Group P ... 13.0 ± 2.18 15 
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The foregoing analysis of cases treated only in military 
hospitals confirms all the conclusions which a corresponding treat- 
ment of the whole sample appears to justify; and thus removes any 
misgivings prompted by the inclusion of cases treated in hospitals 
of the two types. As before we find that the chronic cases are 
moro recalcitrant: 
New Cases Chronic Difference 
Group 0 17.7 ± 0.73 24.5 ± 2.27 6.8 ± 2.4 
Group S 14.5 ± 0.57 18.6 ± 1.38 4.1 ± 1.5 
Group P 11.5 ± 0.74 13.0 ± 2.18 1.5 ± 2.3 
In so far as we are entitled to regard mean duration of 
hospitalisation as a valid yardstick of therapeutic efficacy, the 
foregoing analysis clearly demonstrates the superiority of sulpha 
drugs to agents previously in use and the superiority of penicillin 
to both. From an administrative standpoint, we may approach the 
issue in a different way by exhibiting the figures to bring into 
clearer perspective the proportion of individuals returned to Unit 
within a given period, as below. 
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I.L,L HOSPITAL: MILITARY HOSPITALS ONLY 
10 days 20 days 30 days 10 days 20 days 30 days 
Group 0 30.0 73.4 84.5 31.8 tó8.2 84.5 
Group S 34.3 82.8 87.4 35.7 83.9 91.7 
Group P 47.1 94.1 97.0 49.2 93.7 96.8 
87. 
PART VII. GLNLRAL CONCLUSIONS. 
The remainder of this thesis will deal seriatim with 
general issues raised by the separate investigations recorded 
in Parts II - VI. 
A. Syphilis Therapy in the Army. (Part II) . 
The calculation of Relapse Rates in this trial presented 
a major problem which is not uncommonly encountered in assessing 
results of Therapeutic Trials. The problem does not usually 
arise in ad hoc enquiries as defined above (P. 6 ); but the trial 
on Syphilis therapy was only in part such an enquiry. On the 
whole it must be regarded as a post hoc Lnquiry. As already 
stated, the principal source of information was the Central syphilis 
Register maintained by the Army Medical Directorate. This is a 
register of all men treated for Syphilis, and by means of it, sero- 
logical surveillance is maintained for a period of two years from 
the end of treatment. The register contains notes of initial 
diagnosis and treatment together with results of subsequent serolog- 
ical tests which are performed at statutory intervals. A follow - 
up is thus possible of all patients whether they relapse, are re- 
infected or apparently cured. In general the system works well; 
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but failure in follow -up may arise from any of the following causes: - 
1. Death from any cause other than Syphilis 
2. Desertion from the Army 
3. Clerical errors in reporting to the Central Register 
either by omission to forward documents or by 
giving incorrect information. 
4. Default of the patient to report for surveillance 
regularly. 
5. Loss of documents in transit. 
6. Demobilisation of the patient. 
Nothing can be done to rectify the first two items but 
clerical errors and defaulting can be corrected to some extent be- 
cause the Central Register is constantly audited to ensure that 
patients do continue to have serological tests; and there is comm- 
unication with the treatment centre concerned with the man's f ollow - 
up to obtain the missing information. Since treatment centres keep 
abstracts of treatment and serology of all patients on their regis- 
ter, loss of documents in transit may also be rectified. Loss of 
cases in a follow -up from any of the foregoing causes thus involves 
very small numbers; and there is no known selection to bias re- 
sults if such incomplete cases are omitted from a survey. On the 
other hand the sixth of the above items constitutes a grave source 
of wasted cases at the present time, since demobilised men cannot 
be followed into civilian life. In other respects, the Syphilis 
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trial demonstrates the advantages of medical surveys among an 
army population. A moderate amount of pressure can be brought to 
bear on patients in a way which is impossible among civilians. 
Lconomic factors such as weigh heavily on the individual civilian 
patient, and shortage of beds as occurs in civilian hospital prac- 
tice do not apply to the military patient who is not discharged 
from hospital until he is fit to return to duty. 
In this survey of Army Syphilis Therapy carried out on 
patients treated by several different methods since 1943, it was 
possible to follow many cases for two years, but many more were 
lost owing to demobilisation. in the past, the results of 
Syphilis Therapy have been only roughly assessed, no long -term 
follow -up being possible. Since relapses of sero -negative pat- 
ients after Arsenic Therapy may occur as much as two years subse- 
quent to the end of treatment, possibly longer, loss of cases in 
a follow -up is most important. Such lost cases may be regarded 
in several ways : - 
1. They all remain sero -negative 
2. They all become sero -positive 
3. They become sero -positive in the same 
proportion as the cases which have 
been successfully followed -up. 
The last assumption is the most likely to give the best 
estimate; but if relapse is very late the numbers actually remaining 
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in the follow -up may be so few as to yield figures subject to con - 
dieerable sampling error. The adjustment of the relapse rate to 
take into account the speed of demobilisation presents a difficult 
problem comparable with the computation of a life table for a comm- 
unity subject to large -scale immigration; and is not, as already 
indicated, an insurmountable problem; but the taxonomical problem 
of delimiting relapses as such is beset with several pitfalls. 
In determining criteria of Relapse it was found to be ex- 
ceedingly difficult to distinguish relapse from re- infection. 
Histories are often untrustworthy and cannot be relied on. The 
exact site of the original sore may not have been noted; and it 
cannot be said that a new sore will not occur by re- infection on 
the site of an old one. Therefore, any case with evidence of re- 
newed disease either by serological test only or by other clinical 
manifestations was classified as a relapse. This practice is 
reasonable and is usual among Syphilologists. 
With respect to the choise of a Control Group, each of the 
different treatments provides a basis for comparison with each of 
the others. only control of this sort is possible in a community 
which would not condone failure of the clinician to treat the 
patient in the interest of scientific curiosity. As an example 
of published work the longest follow -up is noted in a report from 
Johns Hopkins Hospital, Baltimore. It was a five -year follow -up 
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of 551 patients suffering from Early Syphilis (primary, early 
secondary and delayed secondary) most of whom were treated with 
Arsphenamine but of whom 17 received no treatment at all. After 
five years the cumulative relapse rate was 34.3%. This series 
was obviously not comparable, because: (a) it includes a wider 
range of casos, viz., delayed secondary syphilis; (b) the cases 
are not homogeneous; some were treated, some were not. 
B. The Use of Paludrine for B.T. Malaria Relapses (Part III) . 
Two issues arising out of this trial call for additional 
comment: 
1. it therapeutic trial must be regarded as a trial of the 
drug only in the specific conditions of the trial and in the dosage 
in which the drug is used. Large or small doses of Paludrine 
given twice daily for ten days only are to all intents and purposes 
ineffective as a cure of Benign Tertian Malaria; but we are not 
entitled to dismiss its usefulness without further consideration. 
Indeed, excellent results have since been obtained by other workers 
giving a small dose twice a week for 6 -9 weeks. 
2. Samples can be made homogeneous only by taking care 
with regard to those factors known to affect the experiment and 
those factors which, there is scientific reason to believe, might 
92. 
affect the experiment. In this instance different phases of the 
life -cycle of the parasite go with different signs and symptoms. 
Since the parasite may well be more or less susceptible in different 
phases of the cycle, timing of the drug may well affect its efficacy. 
From the results of the trial, it did appear that the timing of 
therapy relative to the duration of symptoms was important and that 
Scheme A was biased by having a majority of cases treated early. 
The following table shows the mean interval from onset of symptoms 
to the beginning of treatment for each series of cases. There is 
a statistically significant difference between the mean durations for 
Schemes A and B and for Schemes A and C:- 
No. of Cases Mean days Differences and 
standard errors 
of the Mean 
( A 103 3.4 ) 
Schemes ( ) 0.8 ± 0.35 
( B 103 4,2 ) 
( A 103 3.4 ) 
Schemes ( ) 1.1 ± 0.35 
( 0 103 4.5 ) 
( B 103 4.2 ) 
Schemes ( ) 0.3 } 0.41 
( 0 103 4.5 ) 
Table II of the Report shows that this souroe of bias did 
not suffice to distort the results of the comparison, since Group 
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A consistently had lower relapse rates than Groups B or C during 
a comparable period after onset of symptoms. 
This illustration of unforeseen difficulties of obtaining 
a homogeneous sample in spite of precautions used in selecting com- 
parable patients for the experiment shows the danger of relying on 
judgment in advance to guarantee homogeneity of small samples. 
The particular defect noted here was one which would almost cert- 
ainly have been eliminated in a larger series of cases. 
C. Treatment for Internal Derangement of the Knee (Part IV).. 
This survey of hospital records of men in the British Army 
admitted for treatment of Internal Derangement of the Knee was carr- 
ied out partly as a therapeutic trial and partly to determine the 
pathology of the condition, its causes, and methods and effects of 
treatment. It indicates the weakness of Duration of Hospitalis- 
ation as a criterion of efficacious treatment when hospitals invol- 
ved have different administrations. It also shows that medical 
re- categorisation in the Army can be misguiding when the results 
from different hospitals are compared. Taken at its face value, 
medical downgrading might signify that non -operative treatment in 
B.M.S. hospitals is not so good as in Military hospitals and that 
Army- surgeons are not so good as civilians. In fact, the differ- 
ence was due to the administrative necessity of treating all the 
more serious and long -term cases in E.M.S. hospitals. 
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D. Sulpha Drugs and Penicillin for the Treatment of 
Gonorrhoea (Part V). 
Four issues call for further comment in this context. 
1. The sooner the effectiveness of the treatment can be 
established, the sooner the effectiveness of the treatment can be 
estimated. Immediate criteria of relapse are extremely difficult 
to find even in such an acute infection as Gonorrhoea; and if de- 
layed criteria are used there is always the possibility of confusing 
relapses with re- infections. 
2. Relapses are not always clear -cut. Re- infection with 
respect to Gonorrhoea is easy, and occurs frequently as shown in 
the following table recast from figures given by Paley and Truelove 
'(1946): 
No. of Percentage with 2 Percentage with 3 
Cases or more infections or more infections 
with Gonorrhoea. with Gonorrhoea. 
First Group 254 26.8 6.7 
Second Group 161 20.5 5.6 
TOTAL: 415 24.3 6.3 
Relapses dealt with in Part V were in fact clear -out, there 
being either a sufficient lapse of time to establish cure from a 
previous attack or a recent risk, acknowledged by the patient, of 
re- infection. 
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3. What constitutes a composite treatment for the purpose 
of assessing the efficacy of a single method is not a purely logical 
issue. It is one which calls for first -hand knowledge of current 
medical practice. In this instance, only treatments given simul- 
taneously need be considered as composite. If given successively, 
we may assume that the first treatment failed. 
4. Duration of stay in hospital or other medical unit, 
being subject to changing administrative arrangements, is rarely 
if ever a safe criterion in post hoc ctudies. In a civilian popu- 
lation it might be legitimate if applied in a single centre where 
it was possible to use alternate patients for experimental and con- 
trol groups. 
L. Penicillin Treatment of Impetigo (Part VI). 
The issue of paramount interest raised by this enquiry con- 
cerns the delimitation of a satisfactory control group; and the 
conclusion which emerges is one which received in Part VI more honour 
in the breach than in the observance. In comparing different meth- 
ods of treatment, it is advisable to compare new methods with a 
single method of known efficacy. Here two single methods of treat- 
ment of previously unmeasured efficacy were contrasted with a stand- 
ard comprising a group of different methods whose effects were re- 
garded as being those of a single method. There was, therefore, 
06. 
an all too flimsy basis of comparison, since the standard embodied 
the mean of some possibly good therapies and some certainly bad ones. 
X11 that the trial conclusively proved was that Penicillin is cert- 
ainly moro efficacious than mere inaction. 
The Impetigo trial like others emphasizes that uniformity 
of policy with respect to documentation and procedure is essential. 
The results might have been seriously biased by differences with 
respect to administrative measures current in the different hospit- 
als, if no cognizance had been taken of them. Because Impetigo is 
an infective disease liable to occur in poor living conditions and 
with poor food, homogeneity of socio- economic level is an important 
prerequisite of satisfactory test subjects. The possible bias 
of nutritional factors and different environmental conditions was 
avoidable in this case because the sample was an Army population 
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